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Selected nucleic acid binding species (aptamers) have been shown to undergo 
conformational changes in the presence of ligands, and have been adapted to function as 
biosensors.  We were interested in whether the secondary structures of aptamers could be 
rationally engineered to undergo ligand dependent conformational changes.  To this end, 
we used rational and computational design methods to generate a number of aptamer 
biosensors.   
First, we built upon previous work that showed that antisense oligonucleotides 
bearing reporter moieties could be used to denature aptamers.  Upon addition of ligands, 
the conformational equilibrium is shifted towards release of the antisense oligonucleotide 
and a concomitant increase in fluorescence.  We attempted to adapt this format to the 
potential detection of ricin, but were unsuccessful.   
In order to better evaluate rational designs, we attempted to use computational 
modeling methods.  Again, aptamer biosensors have previously been engineered based on 
 ix
ligand-induced reorganization of secondary structure (as opposed to oligonucleotide 
displacement), a so-called ‘slip-structure’ model.  We developed an algorithm to evaluate 
different lisp structures, predicted both aptamers and aptazymes that should have 
undergone ligand-dependent changes in conformation, and experimentally evaluated the 
computationally predicted sequences.  A number of robust biosensors that could respond 
to the cytokine VegF and the small molecule flavin were discovered.   
The computational model was further adapted to an aptamer biosensor that 
underwent a larger conformational change upon ligand-binding, an antiswitch.  In this 
model, binding of the ligand stabilizes one hairpin structure at the expense of a 
competing structure (as opposed to merely changing the register of the hairpin as in the 
previously described slip structure model).  Again, we were able to computationally 
identify a number of antiswitches that upon synthesis were responsive to the ligand 
theophylline.   
Finally we again attempted to use rational design methods to optimize not just the 
degree of signal but also the kinetic performance of aptamer biosensors.  To this end, we 
developed biosensors that signaled within seconds the presence of the coagulation protein 
thrombin. 
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Chapter 1:  Introduction 
Biosensors are analytical tools capable of transducing analyte detection into easily 
identifiable optical or electrochemical signals.   The ability to sense environmental 
change is derived from interactions between a target and macromolecule, often leading to 
changes within the macromolecule.  Through engineering, these changes can be 
converted into a measurable signal representing the presence of a target, even within 
complex mixtures of nonspecific analytes.  Biosensors have become a critical tool in a 
wide variety of applications including home-based and clinical diagnostics, microbial 
contamination monitoring, and toxin detection.  Most commercially available biosensors 
today rely on antibody or enzyme recognition.  Whereas these methods can be sensitive, 
there are inherent disadvantages to these schemes including short shelf life, high reagent 
consumption and complex or expensive detection methods. 
Nucleic acids have been discovered that recognize a wide variety of ligands 
including nucleic acids and more complex non-nucleic acid analytes both in nature 
(riboswitches) and through in vitro manipulation (molecular beacons and aptamers).  One 
of the simplest nucleic acid biosensors is the molecular beacon (Tyagi and Kramer 1996).  
Molecular beacons are fluorescently labeled oligonucleotide probes that form a stem loop 
structure in which the loop sequence can bind to complementary nucleic acid sequences.  
In the absence of the complementary sequence the two ends of the beacon are paired and 
the fluorescent moieties can interact quenching fluorescence.  When the beacon binds its 
cognate sequence, the two ends are separated by at least the distance of the loop sequence 
such that excitation of the fluorophore leads to a detectable optical signal.  One major 
limitation of molecular beacons is that they are typically only useful for the detection of 
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nucleic acid targets and therefore fail as discriminatory biosensors for ions, proteins, and 
whole cells unless these targets have specific nucleic acid binding properties. 
 
IN VITRO SELECTION OF APTAMERS 
Utilizing in vitro selection methods (Figure 1.1), nucleic acid binding species 
(aptamers) have been raised to detect a wide array of different chemical, biological, or 
physical conditions including ion deficiency, cancer associated proteins, toxins, and 
whole pathogenic bacteria (reviewed in Nimjee, Rusconi et al. 2005; Proske, Blank et al. 
2005; Lee, Stovall et al. 2006).  Aptamers are ideally suited for biosensor applications 
because they undergo ligand-dependent conformational changes, which can be 
engineered to transduce the recognition event into a detectable signal (Hermann and Patel 
2000).  They often display binding affinities similar to antibodies, are reproducibly 
synthesized, can be functionally derivatized and are stable for long periods of time. 
 
 
Figure 1.1.  Selection schema for the manual selection of aptamer nucleic acids.  
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The first selected aptamers were single-stranded RNA molecules capable of 
binding organic dyes (Ellington and Szostak 1990) and T4 DNA polymerase (Tuerk and 
Gold 1990).  To date, many different pools have been utilized for aptamer selection 
including natural nucleic acids such as ssDNA, dsDNA and RNA or modified nucleic 
acids including PNA, LNA, 2’OMe RNA and 2’F RNA.  In its simplest form, functional 
nucleic acids are enriched from random sequence populations of chemically synthesized 
combinatorial oligonucleotide libraries that contain between 20 to 100 random bases.  
These randomized sequence pools provide ample sequence and structural complexity for 
high target specificity.   
The random sequences are often flanked by constant regions required for the 
amplification and reconstitution of the pool.  These portions can contain primer binding 
regions for polymerase chain reaction (PCR) or RNA polymerase promoter sequences.  
Following analyte incubation, functional species are sieved from non-functional species 
by immobilization on columns or through filtration (Figure 1.1).  Functional species are 
then amplified by a combination of reverse transcription, PCR, and in vitro transcription 
depending on the nucleic acid utilized.  Multiple cycles of selection and amplification 
result in the preferential enrichment of those binding species with the highest affinities or 
activities.  Either during the selection or afterwards, the aptamers can be modified for 
increased stability in potentially hostile environments or can be rationally modified to 
with enhanced functionality such as biosensing applications. 
APTAMER BIOSENSORS 
Aptamers can not only be selected against a wide analyte range and therefore act 
as the biorecognition elements, they can also be engineered to comprise the reporter 
domain of biosensors, thus introducing the idea of aptamer biosensors (Bier and Furste 
1997; Osborne, Matsumura et al. 1997).  An aptamer biosensor consists of at least two 
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domains where the aptamer domain binds to an analyte and one or more signaling 
sequences that report the presence of an aptamer-analyte complex. 
One of the first aptamer-based biosensors was an ELISA-based design where an 
aptamer replaced the functions of an antibody in analyte detection (reviewed in Jayasena 
1999).  In this “ELONA”, Drolet et al developed a vascular endothelial growth factor 
(VegF) assay by immobilizing the cytokine on microtiter plates and allowing 
fluorescently labeled anti-VegF aptamers to bind (1996).  Anti-fluorescein antibodies 
were conjugated with alkaline phosphatase and bound to the fluorescein on the aptamers.  
Through this sandwich type assay, VegF concentration was monitored by the addition of 
chemiluminescent alkaline phosphatase.  These assays still required enzymes and 
proteins for detection and had similar limitations to conventional ELISA assays. 
 
Since aptamers often undergo conformational changes upon binding their cognate 
ligands (Burgstaller, Kochoyan et al. 1995; Ye, Gorin et al. 1999; Hermann and Patel 
2000; Patel and Suri 2000), it has proven possible to detect binding without the 
complicated sandwich assays described above.  The structural changes have been 
engineered to report analyte-dependent conformational changes through chemical 
labeling of various moieties in such a way that function (binding) is not perturbed 
(Figure 1.2).  This concept is referred to as a reagentless biosensor where analyte 
detection is possible without the addition of reagents other than the sample.  
 
Figure 1.2.  Reagentless biosensor that produces a signal upon binding a target  
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In Vitro Selection of Signaling Aptamers 
Designing signaling aptamer biosensors typically follows one of two paths.  The 
first method is to develop the biosensor de novo during selection by incorporating both 
ligand detection and signal generation into the sieving mechanism (Jhaveri, Rajendran et 
al. 2000; Nutiu and Li 2005; Morse 2007; Rajendran and Ellington 2007).  This method 
is useful when no aptamer has been selected against a particular target of interest or when 
the a loss of binding affinity is experienced in post-engineered aptamers.  It often 
uniquely combines analyte detection and signaling in a way rational design cannot due to 
the nature of evolution and selection.  However, this process is time consuming and 
limited to the specific analyte/detection method incorporated and considerable planning 
must go into the initial design process. 
Rational Design of Signaling Aptamers 
The second and much more common method is rational design where preexisting 
aptamers are modified to incorporate some signaling domain.  In fact, one of the first 
signaling aptamer constructs that could directly transduce ligand binding into signal was 
developed through rational modification of an anti-ATP aptamer (Figure 1.3 A; Jhaveri, 
Kirby et al. 2000).  The authors incorporated a fluorescent moiety into an unstructured 
internal loop portion of the aptamer, and upon ATP binding the loop was stabilized, 
altering the environment of a fluorescently labeled adenosine resulting in a concomitant 
fluorescence change.  Various incorporation sites were tested and one was found to 
provide a significant signal to noise ratio.  
Since then, dozens of previously selected aptamers have been converted into 
signaling aptamer biosensors by the incorporation of various optical (fluorescent or 
colorimetric) moieties, electrochemical alterations, or by coupling ligand binding to 
ribozyme activity (summarized in Table 1.1). 
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Table 1.1. Signaling Aptamer Utilizing Induced-Fit Mediated Dye-Reorientation.  
References included: 1 (Jhaveri, Rajendran et al. 2000), 2 (Jhaveri, Kirby et al. 
2000), 3 (Merino and Weeks 2005),  4 (Yamana, Ohtani et al. 2003), 5 (Merino and 
Weeks 2003), 6 (Katilius, Katiliene et al. 2006), 7 (Jiang, Fang et al. 2004), 8 
(Wang, Jiang et al. 2005), 9 (Stojanovic and Landry 2002), 10 (Ho and Leclerc 
2004), 11 (Stojanovic and Kolpashchikov 2004).  Adapted from (Cho, Lee et al. In 
Press). 
Strategies for Engineering Fluorescent Structure-Switching Aptamer Beacons 
Whereas electrochemical detection encompasses a new wave of technologies, 
fluorescence is currently the most commonly utilized signaling platform (reviewed in 
Cho, Lee et al. In Press). Fluorescent properties (intensity, wavelength, anisotropy or 
lifetime) change in response to physical or chemical environment perturbations.  
Signaling aptamers are referred to as aptamer beacons if they incorporate a pair of 
fluorescent moieties where signaling is measured by a variation in quenching or 






Signal Mechanism Target NA type Ref
Rhodamine, Cascade blue, Texas 
red/Base_selection
~80% up
Fluorophore environment change --> quantium yield 
change --> intensity change
ATP DNA, RNA 1
Acridine, Fam/base ~80% up
Fluorophore environment change --> quantium yield 
change --> intensity change
ATP DNA, RNA 2
Bodipy/ribose 1.8-3.5X up
Fluorophore environment change --> quantium yield 






Fluorophore environment change --> 





Fluorophore environment change --> Reactivity to FCM to 




2AP, 3MI, 6MAP Fluorescent 
nucleotide
> 30% up
Fluorophore environment change --> quantium yield 








~55% down ATP DNA 8
Cyanine Dye ~50% down
Dye displacement --> Fmonomer (7600nm) vs Fdimer (6700nm) ratio 
change
Cocaine DNA 9
Polythiophene/cation polymer LOD 2 amol
Cationic polythiophene reorientation --> degree of folding 
change --> intensity change
Thrombin DNA 10
MG/aptazyme 8-20X up
Aptamer module catalyze MG aptamer/MG encapsulation 
--> MG quantium yield change --> intensity change










by Hamaguchi et al (2001) by modifying the 15-mer thrombin aptamer (Bock, Griffin et 
al. 1992) with a short oliognucleotide sequence added to the 5’ end complementary to the 
3’ end of the aptamer (Figure 1.4A (red)).  The most stable structure in the absence of 
ligand resembled a hairpin loop akin to a molecular beacon.  Upon thrombin addition, the 
hairpin was destabilized in favor of the native ligand binding G-quadruplex structure.  
When fluorescein and dabcyl were added to the terminal bases of the aptamer, the beacon 
shifted from a quenched state in the absence of thrombin to a highly fluorescent state in 
the presence of thrombin (Figure 1.4A).  The authors tested different extension lengths 
and found that if the hairpin was too stable, the free energy of ligand binding was not 
sufficient to destabilize the beacon conformer.  However, if the hairpin was too weak, the 
G-quadruplex would form and relatively high fluorescence was observed in the absence 
of thrombin.  This rationally designed model can be thought of as a refold signaling 
aptamer due to the refolding of the thrombin aptamer upon ligand binding.  Most of the 
aptamer beacon designs fall into four basic categories explained in the following sections. 
Fold/Unfold  
The first design paradigm involves an aptamer that is generally destabilized such 
that the fluorophore and quencher are separated (Figure 1.3).  Upon ligand binding, the 
secondary structure is stabilized and the fluorophore is brought within proximity of the 
quencher.  Whereas published designs have shown decreased fluorescence upon binding 
due to proximity to quenchers (Figure 1.3B,C), FRET pairs can be utilized and the ratio 
of fluorescence from both dyes can be measured.  Groups have published fold/unfold 
signaling aptamers designs around the anti-cocaine (Stojanovic, de Prada et al. 2001), 




Figure 1.3.  “Fold/Unfold” signaling aptamer beacons. 
Refold/Displacement 
Refold aptamer beacons are more complex in design and involve a global 
conformational change.  Ligand binding involves a restructuring of the secondary or 
tertiary sequence often separating fluorophore from quencher.  As discussed earlier, 
additional sequence can be added to one or both ends of the aptamer to shift the 
nonbinding conformer into a molecular beacon structure incorporating both functional 
moieties into the aptamer itself (Figure 1.4A; Hamaguchi, Ellington et al. 2001; Hall, 
Hesselberth et al. 2007).   
Alternatively, additional oligonucleotides can be designed that hybridize to the 
aptamer and stabilize a nonbinding conformer (Figure 1.4B).  Nutiu et al have designed 
biosensors incorporating the anti-ATP and anti-Thrombin aptamers in either a bi- or tri-
partite model (2003; 2004). Upon ligand binding, the oligonucleotides are denatured 
yielding an increase in fluorescent intensity.   
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Figure 1.4.  “Refold” signaling aptamers. 
Lastly, allosteric aptamer sensors have been designed that couple the binding 
activity of two aptamers where one acts as the “signaling domain” by binding a dye 
(cibacron blue or malachite green) and the other aptamer is capable of binding the desired 
target (Wu and Curran 1999; Stojanovic and Kolpashchikov 2004 respectively).  In the 
absence of target, the dye binding aptamer is shifted away from its native structure and 
incapable of binding the dye.  In the presence of target, a structural rearrangement occurs 
in both aptamers leading to increased fluorescence (Figure 1.4C).  Similar to previously 
published allosteric ribozymes (Tang and Breaker 1997; Tang and Breaker 1998; Soukup 
and Breaker 1999; Robertson and Ellington 2000), Stojanovic et al combined an anti-
malachite green aptamer with either a cocaine or rATP aptamer (2004).  In the absence of 
ligand, the dye binding aptamer displayed little MG binding and subsequence 
fluorescence.  However, when cocaine or rATP were added, both aptamers bound their 
corresponding targets and fluorescence increased.  
 10 
Self Assembly  
In certain cases, stable subunits of one aptamer can specifically self associate in 
the presence of target (Figure 1.5A).  To design these, an internal loop is often broken to 
yield two separate sequences.  On their own, the sequences do not share sufficient base 
pairs to form stable hydrogen bonds at the assay temperature, however when the target is 
added, the free energy from both binding and base pairing stabilizes the aptamer 
conformer.  Both sequence subunits can be labeled with fluorophores (FRET/quenching 
assay), or one of the subunits can be dual-labeled similar to molecular beacons.  This type 
of biosensor has been developed with the anti-Tat aptamer (Yamamoto, Baba et al. 2000) 
in addition to the anti-cocaine and anti-ATP aptamers (Stojanovic, de Prada et al. 2000).  
Figure 1.5.  “Self Assembly” Signaling aptamer beacon. 
Alternatively, multiple aptamers capable of binding different epitopes on the same 
target can be utilized to bring fluorophores within close proximity in an assay design 
similar to proximity ligation reactions previously reported (Figure 1.5B; Fredriksson, 
Gullberg et al. 2002; Pai, Ellington et al. 2005).  In the absence of target, the aptamers are 
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not able to associate in solution due to the weak interaction of complementary tails 
added.  However, when they each bind a single target, the proximity greatly reduces the 
energy needed to self-associate in solution.   When fluorophores were added to two 
different the anti-thrombin aptamers, the addition of thrombin brought the two aptamers 
close enough that FRET based detection was possible (Figure 1.5B; Heyduk and Heyduk 
2005). 
Assisted Refold/Antiswitch 
Figure 1.6.  An “Antiswitch” aptamer design (A) with various signaling pathways 
(B-F). 
One of the current limitations of signaling aptamer beacons is the lack of a signal 
amplification cascade upon binding.  Since aptamer beacons often display reduced 
binding to their targets compared with the originally selected aptamer (discussed below), 
the limit of detection is generally high.  Signal amplification schemes could compensate 
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for this limitation.  Typically, one aptamer beacon “signal” is related to one binding event 
and therefore detection is limited to ligand concentration and the sensitivity of the 
equipment utilized for detection.  A relatively recent and wholly unexplored type of 
signaling aptamer that may overcome this limitation is the assisted refold or antiswitch 
developed by Travis Bayer and colleagues with the anti-theophylline or anti-tetracycline 
aptamers (Figure 1.6A, E; Bayer and Smolke 2005).  The switch works by forming a 
stable conformer that traps or “hides” a sequence through hydrogen bonding (Figure 
1.6A in red) in the absence of ligand.  Upon the addition of ligand, an active binding 
conformer is formed in response to a portion of the aptamer (Figure 1.6A in blue) 
displacing the hidden sequence.  This now free sequence is capable of performing a 
number of different tasks, including activating or inhibiting gene expression in vivo, as 
originally published.  It is also capable of acting as a primer for PCR or rolling circle 
amplification (Figure 1.6C; Yang, Fung et al. 2007).  Although untested, it could initiate 
a hybridization chain reaction originally developed by Dirks et al (Figure 1.6 B; 2004).  
We provide evidence of antiswitch activation of molecular beacons in this work (Figure 
1.6D).  Additionally, the antiswitch could provide allostery for oligonucleotide dependent 
ribozymes (Figure 1.6F; Penchovsky and Breaker 2005).  The possibilities for regulation 
are vast and can include anything where oligonucleotides are currently utilized today.  
Analyte-induced conformational changes.   
Each aptamer biosensor listed above underwent analyte-induced conformational 
changes typically from some unbound “OFF” conformation to a stabilized secondary, 
tertiary or quaternary structure in the “ON” bound state.  There likely exists an 
equilibrium between binding and nonbinding conformers.  The best signaling aptamer 
should be designed such that in the absence of ligand, the nonbinding conformers are 
prevalent, whereas, upon ligand addition, the equilibrium shifts to the binding aptamer. 
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To this end, computational methods can be utilized to predict not only nucleic acid 
structure but structures poised to switch in the presence of some trigger.  
 
COMPUTATIONAL PREDICTION OF NUCLEIC ACID SECONDARY STRUCTURE  
The majority of free energy contained within a nucleic acid molecule resides 
largely in its secondary (rather than tertiary) structure. This secondary structure is 
generally composed of Watson-Crick (A-U/T, T/U-A, C-G, G-C) or wobble (G-U, U-G) 
base pairs.  The secondary structure is stabilized in part by hydrogen bonding between 
the canonical bases and also by “stacking energies” between the aromatic rings (pi-pi 
interactions; Mignon, Loverix et al. 2005).  These stabilizing interactions form between 
base pairs in helical stem structures irrespective of the actual base.  Additionally, non-
paired bases are found in loops and bulges.  To a lesser extent, tertiary interactions help 
stabilize the overall structure and can include pseudo-knots, non-standard base pairings 
and base-triplets (Michel, Ellington et al. 1990; Gautheret, Konings et al. 1994; Leontis, 
Lescoute et al. 2006).   
Nucleic acid secondary structure can be represented in a number of ways, a few of 
which are drawn in Figure 1.7.  Each structure contains some subset of common 
elements called “loops” (recently reviewed in Dirks, Bois et al. 2007). The overall 
structure can be decomposed into a collection of stacked helical stems (two or more 
paired bases), interior loops (two paired bases separated by unpaired bases on each side), 
interior bulges (an interior loop with unpaired bases on only one side), multi-loop branch 
junction (three or more base pairs separated by unpaired bases) and a hairpin loop 
(unpaired bases closed by only one base pair) (Figure 1.7B).  
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Figure 1.7.  RNA Structural Representations from Mfold 3.2.  A.) Primary 
sequence with secondary structure represented in parenthetical notation.  Sections 
are color coded to represent bulges (teal), multi-loop junctions (yellow), hairpin 
loops (purple) and internal bulges (peach).  B.) A generic loop decomposition with 
common elements of nucleic acid secondary structures.  The sequence in (A) is 
capable of forming this structure. C.) The minimum free energy structure of 
sequence (A) along with an alternate suboptimal structure of the top right most 
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stacking helix.  Colors and positions are identical to (A).  Red, blue and green lines 
represent potential base pairs.  D.) Dot-plot showing base pairs (dots).  The lower 
triangle represents the minimum free energy structure whereas the upper triangle 
shows potential alternate base pairs.  This dot-plot is for the sequence (A).  E.) 
Circle graph representation of the sequence in (A) with identical color coding.  It is 
easy to tell from this graph the structural representation does not contain 
pseudoknots as the curved lines do not intersect. 
Structure prediction by dynamic programming algorithms 
The free energy of a nucleic acid secondary structure is the sum of individual 
energies of the constituent loops (Tinoco, Uhlenbeck et al. 1971). It is predicted that the 
number of structures a sequence is capable of forming (N) roughly increases 
exponentially as a function of length (L) following the equation: 
! 
N " (1.8)
L  (Zuker and 
Sankoff 1984).  Even for relatively short sequences (L = 50), there are potentially 5.8E12 
different possible structures.  If a standard PC could calculate 10,000 structures per 
second, it would take 280 years to calculate all the possible structures of a sequence 50 
bases long.  Therefore, the problem is to quickly identify the most common secondary 
structure represented at equilibrium.  For a nucleic acid sequence, this is often the 
structure with lowest free energy.  Using dynamic programming algorithms (DPA) that 
are capable of implicitly predicting this structure without explicitly traversing over all 
possible structures is paramount.  Ruth Nussinov developed one of the first DPAs to 
predict nucleic acid secondary structure from its primary sequence nearly 30 years ago 
(1978).  The “Nussinov” algorithm attempted to maximize the number of base pairs using 
a weighted matrix where G/C was scored 3, A/U(T) scored 2 and G/U(T) scored 1.  
While fast, this crude method did not take into account many of the loop features that 
help stabilize or destabilize nucleic acid structures.  That same year, Waterman and Smith 
described a mathematical description of RNA secondary structural components (loops) 
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and a dynamic programming algorithm to predict these structures (Waterman and Smith 
1978). 
Soon after, computer programs were developed that incorporated thermodynamic 
parameters and refined these DPA methods to determine the secondary structure and 
minimum free energy (MFE) of a sequence (Zuker and Stiegler 1981) (reviewed in: Eddy 
2004; Eddy 2004; Mathews and Zuker 2004; Mathews 2006) and the subset of 
suboptimal structures with the low free energies similar to the MFE (Zuker 1989; 
Wuchty, Fontana et al. 1999).  It is useful to visualize suboptimal structure space as a 
landscape of peaks and valleys where the most stable structure (with the lowest free 
energy) is found in the “deepest” valley and there is some energy barrier for the structure 
to switch conformations into a structure present in nearby valleys.  This concept will be 
expanded on later.  Today, nucleic acid secondary structure prediction is generally 
straightforward using an array of computer programs that utilize the most current 
thermodynamic parameters and sophisticated DPA approaches (Zuker and Stiegler 1981; 
Mathews, Sabina et al. 1999; Mathews, Disney et al. 2004).  
Decades of research have been funded to experimentally determine 
thermodynamic “melting” parameters of loop constructs.  Most of the work has been 
published by two main groups: those of Doug Turner (RNA), and John SantaLucia Jr. 
(DNA) (Walter, Turner et al. 1994; SantaLucia 1998; Xia, SantaLucia et al. 1998; 
Mathews, Sabina et al. 1999; Mathews and Turner 2002). These empirical nearest-
neighbor parameters were discovered by melting specific collections of short double 
stranded nucleic acids and measuring optical absorbance for the phase transition from 
double to single strands.  Both the change in Gibb’s free energy (∆G) and equilibrium 
constants (Keq) can be calculated with these parameters. The initial collections 
represented common structural elements (described in Figure 1.7B) with matrices of 
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closing base pairs that are continually being revised to provide better ∆G estimates.   As 
suggested earlier, the thermodynamic calculation of free energy within a structure is 
merely a summation of the set of individual loop free energies as described by Tinoco 
and colleagues (1971).   The minimum free energy structure is therefore the structure in 
the ensemble with the lowest possible set of free energies (Figure 1.8). 
 
Figure 1.8.  Calculation of structural free energy.  Structural elements and their 
corresponding free energy as calculated by Mfold server v2.3.  The left structure 
represents the minimum free energy for the sequence, whereas the one on the right 
is a suboptimal fold with 1 kcal/mol less energy. 
It should be noted that the experimental processes utilized to determine the 
parameters are not complete and free energy structural predictions are therefore limited to 
Structural 
element ΔG Information
External loop 0 0 ss bases & 1 closing helices.
Stack -3.3 External closing pair is G1-C24
Stack -3.4 External closing pair is G2-C23
Helix -6.7 3 base pairs.
Interior loop 3 External closing pair is C3-G22
Stack -3.3 External closing pair is C6-G16
Stack -2.4 External closing pair is C7-G15
Helix -5.7 3 base pairs.
Hairpin loop 4.1 Closing pair is G8-C14
Free Energy -5.3 kcal/mol
Structural 
element ΔG Information
External loop 0 0 ss bases & 1 closing helices.
Stack -3.3 External closing pair is G1-C24
Stack -3.4 External closing pair is G2-C23
Helix -6.7 3 base pairs.
Bulge loop 1.7 External closing pair is C3-G22
Stack -1 External closing pair is U4-G20
Helix -1 2 base pairs.
Bulge loop 3.3 External closing pair is A5-U19
Stack -3.3 External closing pair is C6-G16
Stack -2.4 External closing pair is C7-G15
Helix -5.7 3 base pairs.
Hairpin loop 4.1 Closing pair is G8-C14
Free Energy -4.3 kcal/mol
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the energy parameters utilized.  In addition, tertiary structure and non-Watson-Crick base 
pairs may affect the predicted secondary structure thus it may not resemble actual 
structures in biological conditions where the nucleic acid is likely to fold.  Whereas free 
energy predictions are extremely useful, they have limitations due to these and other 
assumptions and predictive power is often increased by including alternate information 
such as kinetics of folding, known physical limitations, sequence specific stabilizing 
energies, etc (Dirks, Lin et al. 2004; Shapiro, Yingling et al. 2007). 
Statistical sampling of structural motifs 
The MFE structure is often the dominant structural motif occurring at equilibrium 
for short sequence, however it is often not the only structure a sequence can form at 
equilibrium.  Therefore, statistical methods have been developed to calculate the 
probability of a given structure within the ensemble of potential structures (McCaskill 
1990).  Due to the fact that a sequence is able to form many different weak structural 
interactions, the probability of finding a single structure, even the MFE structure, in the 
entire ensemble of structures is relatively low. However, most of the lowest free energy 
structures share structural motifs in common thus enumerating over all possible base 
pairs is relatively useful (Mathews 2004).   
In addition, a DPA has been developed to sample specific suboptimal structures 
from the complete Boltzmann ensemble of structures (Ding and Lawrence 2003). 
Bayesian sampling methods have also been developed for entire ensembles of possible 
structures (Bayesian and statistical methods reviewed in Ding 2006).  Using these 
methods it became possible to calculate the likelihood that certain base pairs will occur 
and then sample suboptimal structures from an ensemble of structural motifs to find the 
equilibrium probability of any motif.  This overcomes a limitation in the MFE calculation 
for long sequences, which are structurally difficult to predict due to nearest-neighbor 
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assumptions built into the model, inaccuracy of energy parameters and tertiary motifs that 
affect secondary structural arrangements (Doshi, Cannone et al. 2004). 
Alternate methods of structure prediction 
Structures can be predicted from a given sequences and potential sequences can 
also be predicted from a given structure (Andronescu, Fejes et al. 2004).  If multiple 
related sequences are available, comparative sequence relationships via covariance 
models are useful to predict both canonical and non-canonical structural arrangements 
(Gutell, Lee et al. 2002).  Lastly, dynamic programming algorithms have arisen that 
predict the minimum free energy secondary structure of two or more interacting nucleic 
acids (Mathews, Burkard et al. 1999; Andronescu, Zhang et al. 2005; Dirks, Bois et al. 
2007). 
The stochastic folding pathway from linear denatured primary sequence to a 
stable tertiary or quaternary structure will also influence the overall structural 
conformation.  Denatured RNA follows a kinetic hierarchy when forming its most stable 
3-D structure where the secondary structure forms first and then tertiary contacts are 
formed around this “scaffold” (Hall, Hesselberth et al. 2007) (Brion and Westhof 1997; 
Tinoco and Bustamante 1999).  Recently, software to predict these kinetic pathways has 
been developed.  The Kinfold software suite has been developed to aid predictions of 
kinetic folding rates based on conformational pathways and includes a visualization tool 
of folding kinetics (Flamm, Fontana et al. 2000; Xayaphoummine, Bucher et al. 2005).  
Similary, RNAKinetics has been developed to model the folding kinetics of an elongating 
RNA, for instance during transcription (Danilova, Pervouchine et al. 2006). 
Additionally, non-thermodynamic-based methods have been developed to predict 
secondary structures.  Stochastic context free grammars (SCFGs) are a theoretical way of 
describing grammar and languages.  Since RNA represents a combination of loops and 
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helix structures, SCFG rule sets have been developed to predict potential RNA structural 
elements in non-coding RNA (ncRNA) (Rivas and Eddy 1999) and pseudoknot formation 
(Rivas, Klein et al. 2001) without the utilization of empirically derived free energy 
parameters . 
Software and Resources  
Algorithm development is very important to structural prediction, but these 
algorithms themselves aren’t widely useful without implementation through readily 
available software packages.  The two most widely utilized software packages available 
for nucleic acid secondary structure prediction are the ViennaRNA package (Hofacker 
2003) and the MFold related suite of programs (Zuker 2003).  Both are available through 
web interfaces and can be run locally from command line tools.  They utilize the same 
dynamic programming algorithms but differ in the nearest-neighbor parameters for loops 
(multi-branched and exterior).   Additionally, both are in active development with a new 
release of ViennaRNA (version 1.7) released last month (December 2007).   
Some of the other popular computational prediction programs are summarized in 
Table 1.2 and a recent benchmark was published, which compared some of their relative 
performances (Dowell and Eddy 2004).  New resources are published through Nucleic 
Acids Research in its annual “Web Server Issue”, now in its fifth year.  The 
Bioinformatics Links Directory, http://bioinformatics.ca/links_directory, contains an 
actively maintained and comprehensive list of servers and programs for the life sciences 







Table 1.2.  Popular nucleic acid structure prediction software. 
Name Site Programs Use




MFE structure of two input 
DNA/RNA molecules
CombFold
Tests MFE structure from a 
combinatorial set
RNADesigner
Design RNA sequence with a given 
secondary structure
Quickfold MFE and structure for RNA/DNA
Zipfold MFE only for RNA/DNA
Tm Server Melt temp for RNA/DNA
2-state Hyb
Free energy and Tm for 2+ 
DNA/RNA sequences
RNAfold
RNA MFE, structure, pair 
probabilities
RNAeval MFE
RNAheat Melt curve of RNA sequence
RNAinverse
Design RNA sequence with a given 
secondary structure
RNAdistance Compare secondary structures
RNApdist Compare base pair probabilities
RNAsubopt Compare suboptimal folds
RNAplot RNA structure drawings
RNAcofold Hybridization of two sequences
RNAduplex
Predict potential  hyb. between two 
sites.
RNAalifold
Covariance to predict consensus 
structure of multiple sequences
RNALfold
predict locally stable structre of 
long sequences
RNAplfold
average pair probabilities for long 
sequences
RNApaln
Fast structural alignment using 
string alignment 
Perls Scripts Useful output utilities
OligoWalk
Predicts binding affinity to RNA 
targets
DynAlign
Predict consensus structure of 
multiple sequences





Predicts common structures from a 
RNA alignment
Web HTML Interface
paRNAss Alternate RNA secondary structures
RNA Movies
Visualizing secondary structure 
landscapes
RNAforester Alignment of RNA trees
RNAshapes
Secondary structure probabilities 
and concensus structures
many others
Sfold sfold.wadsworth.org/ Srna, others
Statistical predictions for rational 
design of siRNA, antisense 
oligonucleotides, trans-cleaving 
ribozymes, and microRNA
Web Based HTML Interface
NUPACK nupack.org Nupack Nucleic acid design Download/Web Based Linux (Binary/C source)
RNASoft www.rnasoft.ca
UNAFold Download














Download/Web Based Linux (Binary/C source)
RNA Studio







COMPUTATIONAL PREDICTION OF NUCLEIC ACID CONFORMATIONAL CHANGE 
Nucleic acids have been discovered that switch between two or more stable 
conformations.  Examples in nature include transcriptional regulation (riboswitch), 
translational regulation (bacterial terminator/antiterminator), protein synthesis (EF-
Tu/EF-G), mRNA splicing (U6 binding), tRNA maturation, and ribozyme activity 
(reviewed in Nagel and Pleij 2002; Micura and Hobartner 2003).  Likewise, RNA 
conformational switches have been utilized in the rational design of novel biosensors as 
previously stated.  Until recently however, this rational design was experimentally 
validated by trial and error of a vast number of potentially viable constructs.  Most of the 
fluorescent aptamer based biosensors described previously required considerable time 
and effort to test failed constructs. However, there is generally no way to know how 
many unsuccessful attempts were performed before optimal biosensors were developed 
because this information is rarely published.  
Selection experiments have shown that it is useful to screen and select functional 
members from a pool of potential candidates.  It would therefore seem advantageous to 
utilize available computation tools to search for sets of potential switching nucleic acids 
from pools created in silico and select only those with predefined characteristics 
representing an approximate empirical physical model then test the subset experimentally 
for activity.  Using nucleic acid prediction software it has become possible to predict or 
rationally design potential sequences capable of ligand induced structure switching.  
Within the last few years, computational methods have been developed to quickly sieve 
potential structure-switching signaling aptamers in silico (Penchovsky and Breaker 2005; 
Hall, Hesselberth et al. 2007).  In 1999, Robert Giegerich presented a method to predict if 
an RNA sequence is capable of structural switching and wrapped this in a software 
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package for visualization (paRNAss) that followed three rules (adapted from Giegerich, 
Haase et al. 1999; Voss, Meyer et al. 2004): 
1. There must exist two distinct energy minimum “valleys” representing 
stable yet significantly different structures such that one must be the 
global energetic minimum and the other must be found in a structure 
space with local minima near by. 
2. The structures must be separated by an energy barrier to ensure that 
they exist as two separate structures and the switch between them is 
only triggered by external events (Flamm, Hofacker et al. 2001). 
3. There must not exist other local minima for the RNA to become 
trapped in once the change has been triggered. 
Predicting the possibility of structural switching from known natural switches 
based on sequence was utilized to proof the algorithms presented by paRNAss.  This 
problem was followed by a method to design a sequence capable of forming predefined 
structural alternatives (Flamm, Hofacker et al. 2001).  Flamm and colleagues presented 
three examples: (A) create a sequence that consists exclusively of two distinct, predefined 
structures, (B) create a sequence that is capable of switching structures at a certain 
temperature and (C) create a sequence with two structures contained in local minima 
separated by a predefined energy barrier.  This last example represents one of the most 
important factors influencing folding kinetics (Flamm, Fontana et al. 2000).  In a 
simplified form, the energy barrier between two local minimum structures can be 
calculated by determining the distance in base pairs needed to convert one structure into a 
less stable structure common to both.  This distance measure is paramount to the 
effectiveness of each model, and various methods are under considerable research.  It 
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should be noted that experimental validation of the predicted sequences presented by 
Flamm and colleagues was never published. 
Researchers in the lab of Danny Barash have also developed computational 
methods for the design of small riboswitches (Avihoo and Barash 2006) and 
thermoswitches (Avihoo, Gabdank et al. 2007) using computational methods.  Instead of 
dynamic algorithm approaches that utilize thermodynamic parameters, they incorporate 
tree-graph theory and have developed eigenvalues to predict switch structures.  
Unfortunately, the data presented did not provide conclusive evidence that the methods 
were capable of accurate prediction due to unforeseen structural intermediates and the 
inability to predict effects of activation energy. 
Thermodynamics and kinetics of nucleic acid conformational change 
To understand the conformation structure switching designs presented above, it is 
imperative to provide a basal understanding of energetics and their relationship with 
respect to free energy and equilibrium constants as they relate to signaling aptamers.  For 
any nucleic acid capable of forming secondary structure, there exists an equilibrium 
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such that [S1] is the concentration of structured sequence and [RC] is the concentration of 
the random coil.  The stability of any potential structure formed by a sequence can be 
quantified by the change in Gibbs free energy from the random coil to a structured state 









Nucleic acid folding happens at micro- and millisecond time frames so during 
experimental assays, the structural representations of the sequence is at equilibrium (ΔG 
= 0) and thus standard Gibbs free energy is utilized.  By rearranging equation (3) we 






" #G°37 (S1 )/RT( )  
corresponds to the change in standard free energy (ΔG°37) of S1 from the random coil, 
where R is the gas constant (1.987E-3 kcal/mol/T) and T is the absolute temperature in 
Kelvin. In nucleic acid structure prediction, T is often 310° Kelvin (37°C).  ΔG° is in 
units of kcal/mol, whereas K a ratio and therefore unitless.  Additionally, the difference in 
structure stability between two structures from the same random coil can be calculated 
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Figure 1.9.  Graphical representation of Equation (5).  The x-axis is the change in 
ΔG.  The Y-axis corresponds to the molar ratio of more stable to less stable 
structures. 
It is apparent from a graphical representation of equation (5) as shown in Figure 
1.9 that the farther a suboptimal structure’s free energy is from the minimum free energy, 
the less it is represented in solution.  A typical cutoff is +3 kcal/mol of the MFE structure 
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which corresponds to a ratio of 1:150 between structures of X kcal/mol and 3+X cal/mol 
at equilibrium (Flamm, Hofacker et al. 2001).   
As stated earlier, the free energy of the entire structure ΔG°37(S1) is calculated by 
the summation of individual nearest-neighbor loop energies determined experimentally: 
(6) 
! 
"G°37 S1( ) = "G°37 loop( )
loop#S1
$  
Two state model of structural switching nucleic acids 
Signaling aptamers display coupled equilibria between binding and 
conformational switching.  To begin designing aptamer-based biosensors, we must first 
start with a switching model such as those presented above.  For this example, the “refold 
beacon” switch structure will be utilized.  The goal is to take a known aptamer sequence, 
and append some additional sequence such that it is shifted out of its native binding 
conformation, i.e. the “aptamer conformer”.  Upon addition of ligand however, the 
aptamer conformer should be stabilized such that the structural equilibrium shifts from 
the non-native conformer to the aptamer conformer.  To do this, a sequence is designed 
such that it incorporates the aptamer sequence and random portion where the minimum 
free energy structure has paired nucleotides at the 3’ and 5’ terminus (Figure 1.10A) thus 
forming the non-native structure herein termed the “MFE structure”.  This provides a 
quenched state if fluorescent and quenching moieties are derivatized to the ends (green 
star and red dot in Figure 1.10A).   
 27 
 
Figure 1.10.  Phase diagram for refold aptamer beacon. A.) Possible folding 
pathways (black arrows) with equilibrium constants (in purple).  In a two state 
model, the aptamer sequence can fold into either an unbound aptamer conformer or 
unbound MFE conformer depending on the relative thermodynamic stabilities 
between the two structures.  Upon ligand addition, the aptamer conformer should 
be stabilized shifting the structural equilibrium towards the aptamer conformer.  B.) 
An energy diagram representing the relative free energies of the various conformers 
(red) and the energy barriers that prevent rapid switching between states. 
In a two state model, this sequence should also be capable of forming a second 
stable structure with a local energy minimum different from the global energy minimum 
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(as suggested in Rule 1 by Flamm et al (2002) above).  This second structure should be 
capable of binding the analyte, and thus contain the aptamer structure.  In the “refold 
model,” the second structure should also shift the terminal nucleotides such that the 
derivatized fluorophore and quencher are separated, yielding a signal.  Figure 1.10A 
represents a phase diagram of this switch whereas Figure 1.10B suggests a possible 
conformation landscape with energy barriers for switching.  Both structures may exist at 
equilibrium in the absence of ligand, however the trigger for switching should be 
provided by the addition of ligand and is therefore a coupled equilibrium of binding and 
structure switching. 
Equilibrium Analysis of two-state ensemble model  
In the two state model, we propose that the aptamer beacon exists in two states in 
the absence of target in solution: MFE structure and an aptamer conformer.  It is unlikely 
that a significant proportion of molecules exist in the random coil state, but this state is 
necessary to calculate equilibrium constants.  Also, we realize that an ensemble of 
structures may exist; however we simplify the model for explanation.  In the next section 
we discuss parameters that could be incorporated to account for events such as a 
structural ensemble.   
A concise equilibrium analysis has been proposed for molecular beacons, and we 
expand it here to incorporate aptamer switching structures (Bonnet, Tyagi et al. 1999).  
The states and transitions are presented in Figure 1.10A (blue) and include a random coil 
(RC), MFE structure (MFE), unbound aptamer conformer (UBA) and ligand-bound 
aptamer conformer (BA) with their associated equilibrium constants (purple).  The target 
ligand is represented as T.  The fluorescence of the solution at a given temperature is can 





















where α, β, γ, and φ, represent the fluorescence of the aptamer beacon in each state and 





= [RC]+ [MFE]+ [UBA]+ [BA]  
The equilibrium constant for the dissociation of structures to random coil can be 
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whereas the equilibrium constant for the dissociation of the aptamer-ligand complex can 
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When ligand is saturating, the total concentration of target To is much greater than the 
concentration of aptamer beacon Ao, therefore [T] = To.  Provided the structured aptamer 
has a sufficiently low ΔG, the equilibrium constant KMFERC approaches 0 according to 
equation (5).  This means that in solution, the unstructured aptamer (random coil) is 
virtually not present.  Dropping this term, the fraction of aptamers in each state can be 
expressed in terms of the target concentration and the two equilibrium constants 









































and substituting these four equations into equation (7) the fluorescence of a solution of 
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aptamer beacons can be fully described as a function of temperature and ligand 














Thermodynamic substitutions for two-state ensemble model 
Each of the equilibrium constants can also be elucidated experimentally through 
fluorescence measurements as described below using a standard concentration of 
fluorescent aptamer. The transition of aptamer beacons from the unbound aptamer 
conformer to the minimum free energy conformer in the absence of ligand (To = 0), can 













where F is the fluorescence of the reaction at equilibrium, β is the characteristic 
fluorescence of a fully denatured aptamer (found by measuring the fluorescence of 
aptamer at 80°C) and γ is the characteristic fluorescence intensity of the aptamer in the 
fully quenched state (this value can either be measured or calculated through the 
quenching efficiency of the fluorophore:quencher pair (Marras, Kramer et al. 2002)).  It 
should be noted that the aptamer in the ligand binding conformer will have a fluorescence 
intensity (β) nearly identical to the denatured aptamer (φ) if the fluorophore and quencher 
are sufficiently separated.  Also, it should be tested whether ligand-binding acts to 
quench the fluorophore, which will change the fluorescence intensity of the bound (α) 
verses unbound (β) aptamer conformers.  Both of these conditions can be tested 
experimentally. 
The equilibrium constant for aptamer binding (KBAUBA) is analogous to the 
dissociation constant (kd) of the aptamer.  The dissociation constant represents the ligand 
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concentration where 50% of the aptamer is bound and 50% of the aptamer is unbound.  
Quite often however, switch-structure signaling aptamers display higher binding 
constants than the aptamer alone.  Since most switch-structure signaling aptamers are 
designed to occupy two conformations (active “binding” and inactive “MFE”), only one 
of these (the active conformer) is capable of binding the target analyte.  There is no way 
to predict a priori to what extent sequence modifications will affect the aptamer 
dissociation constant, however we can adjust for this in the design process by adding a 
factor (χ) to the kd of the aptamer: 
(17) 
! 
KBA"UBA = #(kd (aptamer))  
and by experimental determination via a ligand binding assay.   
Through these equations, it should now be possible to model fluorescence 
intensity change as a function of protein concentration for any signaling aptamer beacons 
that switch via a refold mechanism as shown in Figure 1.10.  Likewise, by modifying the 
phase model above, it should not prove difficult to predict signaling characteristics of the 
aforementioned signaling aptamer designs. 
Ensemble model of nucleic acid structural landscapes 
The ensemble model is similar to the two state model except a Boltzmann 
distribution of structures at equilibrium replaces the equilibrium constant KUBAMFE.  For 
instance, if the partition function (described above) is utilized to design a signaling 
aptamer where the probability of forming the active analyte binding conformer accounts 
for 2 percent of the structural population, then there is a coupled equilibrium between the 
two percent bound or unbound and the population dynamic capable of switching between 
active and inactive structures.  In practice, this distribution should be limited to sequences 
that fall into two separate but similar local energy minima as described by the rules 
presented by Flamm et al (2002).  Also, these suboptimal structures should be manually 
 32 
verified for characteristics that will promote ligand-mediated fluorescent signaling.  In 
the aptamer beacon example above for instance, the population of inactive conformers 
should consist mostly of structures with paired terminal nucleotides. 
 
CONCLUSIONS 
Given the recent advances in nucleic acid structure prediction, developing generic 
methods to couple analyte binding and optical signaling by target-specific nucleic acid 
aptamers has become a tractable problem.  The focus of this thesis is studying the 
mechanisms by which an aptamer modulates folding.  To this end, generalized methods 
have been developed to model the secondary structural changes that aptamer-based 
biosensors undergo.  This information was useful to generally relate energetics, structural 
folds and function.  Computational techniques were created to scan large sequence pools 
for sequences predicted to fold into certain conformers deemed active and experimental 
validation was provided of their switching capabilities.  This ultimately led to the 






Chapter 2: Tripartite refold aptamer beacon to detect threat agents. 
 
INTRODUCTION 
Some of the most toxic substances found on earth are produced naturally by 
bacteria and plant species.  The Merck Index reports the class II ribosome-inactivating 
protein ricin produced in the castor bean of Ricinus communis has a median lethal dose 
(LD50) of around 1ug ricin per kg body mass whereas the causative agent of botulism, 
Clostridium botulinum, has an LD50 in mice of 0.3ng botulin per kg body mass (2006).  
Thirty years ago the Russian KGB was suspected of using ricin to murder the Bulgarian 
dissident Georgi Markov by an small prick from an umbrella.  A number of aptamers and 
biosensors have been raised against potential or actual biothreat agents (reviewed in 
Ligler, Phil et al. 2006).  For instance, both RNA and DNA selections have been 
performed against the ribosome-inactivating proteins ricin (Hesselberth, Miller et al. 
2000; Tang, Xie et al. 2006; respectively) and abrin from Abrus precatorius (Tang, Yu et 
al. 2007).  
DNA and RNA selections have also been performed against disease causing 
bacterial targets.  A DNA selection against the adhesion protein PilS from Salmonella 
enterica serovar Typhi, the causative agent of typhoid fever, was shown to reduced cell 
invasion (Pan, Zhang et al. 2005).  Additionally, an RNA aptamer raised against the 
PTPase tyrosine phosphatase was found to inhibit the dephosphorylation of 
phosphopeptides by Yop51 (Bell, Denu et al. 1998).  Yop51 is a virulence determinant in 
Yersinia pestis, which is known to cause bubonic plague. 
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The anti-abrin aptamer was converted into a signaling aptamer upon ligand 
dependent binding of the fluorescent dye reporter [Ru(phen)2(dppz)]2+.  In addition, 
aptamer based sensors have been developed to detect ricin utilizing microarray 
technology (Cho, Collett et al. 2006), so called “electronic tongue” (Kirby, Cho et al. 
2004) and capillary electrophoresis (Haes, Giordano et al. 2006).  Aptamers frequently 
undergo small, analyte-induced conformational changes (Hermann and Patel, 2000).  By 
appending fluorescent labels to the aptamer, this change in conformation may be 
exploited to produce a signal in response to the target.  Because the general structure of 
nucleic acids can be predicted from simple base pairing, it is also possible to engineer 
aptamers to undergo larger conformational changes in the presence of the target. 
In order to design aptamer beacons that respond to biothreat agents, we employed 
a tripartite strategy in which an antisense oligonucleotide leads to the denaturation of an 
aptamer in the absence of ligand (Figure 2.1; Nutiu and Li 2003).  However, in the 
presence of the cognate analyte, the native aptamer structure forms and the antisense 
quencher strand is displaced.  By appending a sequence to the end of the aptamer 
complementary to a fluorescently labeled oligonucleotide, target binding (and quencher 
oligonucleotide release) can be monitored by an increase in fluorescence.   
 
Figure 2.1.  Tripartite aptamer beacon construct.  The fluorescently labeled 
oligonucleotide binds to a sequence (red strand) that is appended to the ATP 
aptamer (black strand).  Upon ATP binding, the quencher oligonucleotide is 
displaced yielding an increase in fluorescence. 
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The goal was to rationally modify aptamers previously selected to bind ricin (both 
DNA and RNA) and Yop51 RNA aptamer for signaling in total internal reflection 
fluorescence (TIRF) microscopy assays.  We tested both fluorescent activation via a 
fluorescent microplate reader and protein binding via filter binding assays.  Likewise, 
various constructs were synthesized to determine the optimal length of antisense 
quencher and fluorescent oligonucleotides along with distance from the potential core 
binding sites of the aptamer.   Whereas we could reproduce native binding with various 
constructs and perturb it with various antisense oligonucleotides, none of the rational 
designs exhibited protein dependent signaling.  This was potentially due to poorly 
elucidated structural requirements within the aptamer necessary for binding, but could 
also result from the large aptamer size and a lack of ligand induced conformational 
changes. 
 
RESULTS AND DISCUSSION 
Design influences and requirements by TIRF Technologies 
This project was initially developed in conjunction with TIRF Technologies 
(Morrisville, NC) to design aptamer sensors utilized in total internal reflection fluorescent 
(TIRF) microscopy (Figure 2.2).  This sensor platform works through evanescent wave 
penetration across an interface of two materials with different refractive indexes (Figure 
2.2B).  When the excitation wavelength is fully reflected by the first material (typically a 
glass slide), a highly restricted electromagnetic field identical in wavelength is created 
within 100nm of the surface of the second material (a flow cell), which can be utilized to 
excite fluorophores immobilized at the surface (Rumbles, Brown et al. 1991).  This 
method helps to limit the background signal typically present in a fluorescent solution. 
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To this end, we began designing aptamer beacons that could be immobilized on 
beads for the detection of biothreat agents through displacement of a quenched moiety 
leaving behind a fluorescently encoded bead (Figure 2.2C).  We chose to model aptamer 
sensors on tripartite designs previously published (Nutiu and Li 2003) and worked with 
the characteristics of the TIRF platform including attachment chemistries and dye usage.  
The TIRF Technologies microscope utilizes a 532 nm laser for excitation (Figure 2.2A), 
so initial plans for this project focused on using Alexa532 as the fluorescent reporter and 
the Iowa Black quencher to best align with the detection capabilities of the TIRF 
platform. Commercially available organic fluorophores that could be directly 
incorporated into the aptamer constructs during chemical synthesis were utilized 
eliminating the need for post-synthesis conjugations and further purification resulting in 
loss of material.  
Another aspect of the design was the difficulty in immobilizing transcribed RNA 
onto a surface.  We hoped to incorporate biotin during in vitro transcription of RNA 
aptamers, as opposed to modifications and purification that may reduce yield after 
transcription. We agreed on Adegenix’s altered biotin-AMP substrate, which could be 
utilized to prepare 5' biotin-labeled RNA through a single transcription step and high 
biotinylation yields (70-80%) (Figure 2.3 and Huang, Wang et al. 2003).  This allowed 
aptamer beacon immobilization to streptavadin coated microsphere beads, a condition 








Figure 2.2.  Bead immobilized refold aptamer beacon and TIRF microscopy 
detection.  A.) TIRF microscope B.) Diagram of flow cell detection of analyte (T) 
by bead immobilized aptamer (inactive: gray circle or active: yellow circle).  The 
excitation wavelength is fully refracted, yet an evanescence wave travels ~100nm 
into the flow cell to excite the fluoresceinated aptamer. C.) Bead level diagram 




Figure 2.3.  Altered biotin incorporation via transcription.  Adegenix’s altered 
biotin-AMP incorporated with the following T7 RNA polymerase binding site: 
TAATACGACTCACTATTAGG.  The bold A is the first RNA base incorporated 
during transcription representing the biotin-AMP .   
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Anti-ricin DNA signaling aptamer design 
Initially we set out to design aptamer beacons around DNA aptamers selected 
against ricin (Tang, Xie et al. 2006). The original aptamers were selected against the 
entire ricin dimer (A and B chains).  However, in order to carry out both engineering and 
TIRF-based detection under BSL 2  laboratory conditions (or lower) we only utilized the 
commercially available A-chain for assays.  RTA is incapable of penetrating cellular 
surfaces without the addition of the B-chain (Lord, Hartley et al. 1991).  
We began with sequence C5 from a number of possible candidate sequences 
nanomolar binding affinities(Tang, Xie et al. 2006).  Because the sequence had not been 
well-characterized, we began by making a series of deletion constructs to elucidate the 
most important structural motifs required for binding.  We designed and synthesized 4 
different deletion constructs in addition to the original C5 aptamer and tested them for 
binding (Figure 2.4B).  C5.2 and C5.3 were designed to test whether ricin bound and 
stabilized the hairpins into a four-way junction similar to the PDGF and cocaine signaling 
aptamers (Figure 2.4A; Stojanovic, de Prada et al. 2001; Fang, Sen et al. 2003 
respectively).  C5.3 and C5.4 represented minimum aptamer sequences that would 
stabilize a potential G-quadruplex to determine if it was responsible for binding similar to 
the anti-thrombin aptamers (Bock, Griffin et al. 1992).  
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Figure 2.4.  DNA binding aptamers for ricin. Bold sequence denotes primer 
binding sequences for PCR amplification.  G to A transition (red circle) in clone C1 
destabilizes the small hairpin. Thymine deletion in C5 (yellow circle) changes loop 
dynamics.  C5 has a Kd of 58nM, C1 displays a Kd of 80nM whereas A3 has a Kd 
of 105nM.  The small hairpins near the 3’ end were not stable in the subpopulation 
of sequences. B.) C5 ricin aptamer sequence and 4 modified sequences.  Bold 
sequence represents the primer binding sites as above, blue sequence is a duplex 
that could potentially stabilize the terminal nucleotides. 
Unfortunately, we were unable to detect binding with the original C5 aptamer or 
any of the deletion/mutation constructs (data not shown) suggesting that the original 
aptamer was specific for either the entire ricin dimer or the B chain alone.  
Anti-ricin RNA signaling aptamer design 
It would have been preferable to work with a DNA aptamer due to the ease with 
which constructs can be synthesized, however the lack of detectable protein binding 
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prevented its utilization.  We therefore began developing sensors based on anti-ricin 
RNA aptamers originally developed in our lab by Jay Hesselberth (Hesselberth, Miller et 
al. 2000).  One of the published aptamer sequences was found to bind ricin A-chain 
(RTA) with high affinity (Kd of 7.4 nM +/- 1.1 nM) and selectivity.  This aptamer 
sequence contained a GAGA known to be universially conserved in eukaryotic 23-28 S 
rRNA and to which RTA was found to be catalytically active (Chen, Link et al. 1998).  
However, this sequence is capable of forming a number of strucurally diverse species 
based on computational folding by free energy minimization.  Therefore, Hesselberth and 
colleagues tested two minimal sequence variants that either stabilized a structure in which 
the  GAGA tetramer was sequestered in a stem (RA80.1.d1) or another in which the 
GAGA tetramer was displayed in a hairpin loop (RA80.2.d1).  The authors hypothesized 
that the exposed GAGA would provide tighter ricin binding since it resembled the 
naturally occuring tetraloop.  Their data however, suggested that RA80.1.d1 was infact 
the most likely structural variant able to binding RTA even though the GAGA tetramer 
was sequestered.  They then further minimized this sequence (31RA) to detect whether 
the GAGA was necessesary for recognition and binding or could be removed entirely.  
This new aptamer bound with a Kd 30 fold lower than the original unmodified aptamer 
suggesting the tetramer was not imporant.  It was noted however that a purine rich 
GGGG tetramer was displayed in a hairpin loop and this may be sufficient for tight 
binding.  
Since the longer aptamer was capable of forming a number of conformational 
variants and only a handful of them were shown to bind ricin we incorporated this 
potential conformational switching into designs.  We designed a number of constructs 
with various stem lenghts and compared binding of these to the original and minimal 
published aptamers.  The full-length aptamer RA80.1 and the minimal aptamer 31RA, 
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were transcribed and binding was confirmed by nitrocellulose filter binding assays in the 
presence or absence of RTA.  The percent binding was calculated as the fraction of RNA, 
which could bind the nitrocellulose filter.  This is typically very low in the absence of 
protein target and increases when the protein is present.  Both RA80.1 and 31RA could 
be captured at equimolar concentrations of RNA:protein (Figure 2.5, left two 
constructs) however to a lesser extent than previously published.  
 
 
Figure 2.5.  RNA ricin aptamer binding assay.  The structural conformations of 
each construct are shown above (or below) the respective binding assay in the 
presence or absence of RTA. 
Based on these results we began to model sequence modifications for the 
conversion of the aptmers into signaling aptamers using tripartite refold designs 
described previously (Figure 2.2 C; Nutiu and Li 2003).  In short, we wanted to develop 
a signaling aptamer that in the absence of protein effector would stably hybridize to 
quencher- and fluorophore-labeled oligonucleotides, but in the presence of the protein 
effector the aptamer would displace the quencher oligonucleotide, ultimately resulting in 
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an increase in fluorescence.  A series of constructs (RA.80.d5 through RA80.d11) were 
designed and made.  RA80.d11 also contained the sequence AGGA at its 5’ end required 
for transcription and incorporation of biotin derivatized adenosine, however as a control, 
this biotin was not incorporated for the binding or activation assays such that native 
binding could be determined.  Binding assays of all modified sequences were performed 
and (surprisingly) they yielded enhanced ricin-dependent binding with little to no 
increase in filter binding alone (Figure 2.5).  Additionally, we found rescued binding by 
including an oligonucleotide that would hybridize to the 3’ portion of RA80.d11 thus 
stabilizing the predicted binding structure (compare RA80.1 with RA80.d11, Figure 2.5). 
Other experiments (not shown) confirmed the specificity of binding.  
A number of quencher oligonucleotides were designed with predicted melting 
temperatures and sequence length characteristics similar to those originally designed by 
Nitiu et al such that they would disrupt the aptamer secondary structure (Figure 2.6A; 
red sequences).  We hoped they would also display similar activation levels. 
As can be seen in (Figure 2.6B red and green bars), no ricin dependent 
activation was detected.  The maximum fluorescence in which no quencher was present is 
about 9-fold greater than in the presence of the longest quencher Q0 and quenching was 
dependent on the presence of the RNA aptamer (compare No Q, and Q0 with or with out 
RA80.d11 in Figure 2.6B).  Whereas the longest quencher (Q0) presumably bound and 
quenched fluorescence, when the sequence length was shortened the quenching 
efficiency also reduced to the point in which the quencher presumably no longer 
efficiently hybridized to the aptamer.  
To ensure that the aptamer was capable of binding ricin in the presence of the 
added fluorescent oligonucleotides, a binding assay was performed with radiolabeled 
aptamer constructs.   Figure 2.6C shows that F0 does not inhibit binding, however Q0 
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does partially inhibit binding compared to Q3 but does not completely abolish it.  This is 
in line with the predictions based on our knowledge of structure-function relationships in 
the aptamer.  However, the inhibition of binding by Q0 is relatively small, and thus the 
potential for signal generation is also small. 
 
 
Figure 2.6.  Sequence designs and assays for RA80.d11.  A.) RA80.d11 structure 
with F0 oligo hybridized.  Red bars indicate relative placement of the red quencher 
sequences. Also included are the predicted melting temperatures for each oligo.  B.) 
Activation assay of RA80.d11 with F0 and different quencher constructs.  C.) 
Binding assay of two quencher constructs in the presence or abasence of ricin.   
We reasoned that Q0 was sufficiently stable under assay conditions and thus 
difficult to displace. Also, since Q3 did not display quenching, the 5’ portion of the 
aptamer was capable of forming a more stable duplex with itself than the antisense 
quencher oligonucleotide.  Displacement could be achieved by either increasing the assay 
temperature to universally destabilize hydrogen bonding or shorten the 5’ portion of the 
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aptamer and utilize one of the shorter antisense quenchers.  It was necessary to reduce 
observed competition without increasing the assay temperature since this would also 
destabilize potentially imporant structures required for aptamer-ligand interactions.   
Following these considerations, several deletion variants of the original RA80.d11 
were made in which 2, 4, 6, or 8 residues were removed from the 5’ portion of the hairpin 
stem.  When 2 bases were removed and the aptamer was tested with F0 and either Q0 or 
Q3, a reduction in binding was observed.  However, when 4 bases were removed, there 
was no observable difference in binding activity with either Q0 or Q3 (Figure 2.7).  In 
the absence of RTA, background binding was consisiently below 3% (data not shown). 
 
 
Figure 2.7.  Binding assay in the presence of antisense quencher Q0 or Q3 and 
fluorescent oligonucleotide.  RNA was RA80.d11 with 2, 4, 6 and 8 bases removed 
from the 5’ end of the aptamer.   
When 6 bases were removed from the 5’ end of RA80.d11, ricin-specific binding 
was partially lost, but could rescued by the addition of the fluorescent oligonucleotide.  
This would suggest the sequence predominatly forms an inactive conformer that prohibits 
ricin binding, but when a portion of the sequence is sequestered by the fluorescent 
oligonucleotide, the native binding conformer prevails (Figure 2.7; RA80.d11.f6).  
When 8 bases were removed, binding was inhibited irrespective of the presence of F0 
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(Figure 2.7; RA80.d11.f8).  We propose that destabilization of the stem structure in fact 
poised the aptamer for a conformational change related to ricin-binding.  When the 
quencher oligonucleotides were added to RA80.d11.f6, they also inhibited ricin binding, 
consistent with this interpretation.  Indeed, now Q3 as well as Q0 could suppress ricin-
binding. 
The various deletion constructs were also assayed for ricin dependent 
fluorescence increases, however, no fluorescent changes were observed (Figure 2.8).  It 
again appeared that whereas the oligonucleotides are influencing the binding ability of 
the aptamer, there was no detectable ricin dependent conformational switching between 
quenched and unquenched states.  Unlike previous constructus however, in which the 
quencher oligonucleotide shows less quenching ability (Figure 2.8: RA80.d11-f4 Q3) 
full ricin binding is observed. 
 
Figure 2.8.  Activation assay of 5’ aptamer deletion constructs in the absence (red) 
or presence (green) of 1.33uM RTA after 30 minutes. 
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Anti-YOP signaling aptamer designs 
Ultimately, we did not observe ricin dependent activation although we could 
inhibit binding with stable quencher oligonucleotides or reduce quenching with unstable 
quencher oligonucleotides.  Therefore, we decided to switch to a different aptamer known 
to bind biological targets of interest. 
To this end, we began working with an anti-tyrosine phosphatase (PTPase) RNA 
aptamer previously developed in our lab (Bell, Denu et al. 1998).  The phosphtatase is a 
product of the Yop51 gene of Yersinia enterocolitica, a close relative of the pathogen 
Yersinia pestis.  We incorporated the anti-Yop51 aptamer N71yc2 into our experiments 
due low nanomolar binding affinities similar to the anti-ricin RNA aptamer (18 nM).   
Using the same methods as previously described, we designed a number of 
antisense quenchers (Yc.2.Q1-3), and an extended the aptamer (N71yc2.d2) with the 
additional 3’ sequence capable of hybridizing to a fluorescently labeled oligonucleotide 
(Yc.2.F1) (Figure 2.9A).  We again performed a binding assay to show that the presence 
of the additional fluorescent oligonucleotide did not prevent the aptamer from binding 
Yop51 (Figure 2.9B).  As was the case with the anti-ricin aptamer the quenching 
oligonucleotides do not appear to inhibit Yop51 (Figure 2.9B) and in fact their presence 
restores full binding.   
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Figure 2.9.  Activation and binding assay for anti-Yop aptamer beacon.  A.) Anti-
YOP aptamer with Yc.2.F1 hybridized and the quencher oligos in red. B.) Binding 
assay of anti-YOP aptamers N71yc2.d2. C.) Quenching assay of the anti-YOP 
aptamers N71yc2.d2 with various quenchers after 30 minute equilibration at room 
temperature. 
We therefore tested ligand dependent antisense quencher displacement, and to our 
surprise, none of the quencher oligonucleotides were capable of hybridizing to the 
aptamer in the absence of target (Figure 2.9C).  This was expected for Yc.2.Q3 and 
possibly for Yc.2.Q2 based on Tm comparisons with previous ricin constructs, however 
Yc.2.Q1 should have formed a stable duplex with the aptamer. The most likely 




CONCLUSIONS AND PROSPECTS 
This project was primarily driven by a collaboration with TIRF Technologies, 
however we also utilized it as a chance to rationally design aptamer beacons and to 
decipher to what extent design parameters had on binding or activation.  Due to the late 
arrival of funding, we were able to initiate but not complete the development of protein 
biosensors.  However, we have done exactly what might have been expected within the 
short timeframe that was allowed:  develop initial constructs that are active in binding 
and can hybridize fluorescently labeled oligonucleotides.  One of the advantages of the 
methods developed here is that since both the fluorescent reporter and the quencher are 
on separate oligonucleotides, they can be modularly added to the aptamer in various 
combinations without the need for resynthesis.  This design decision saved us a great deal 
of time during execution. 
All that remains is to optimize both the aptamer structure and the quencher 
oligonucleotide sequence to more finely poise the constructs to signal in the presence of 
protein analyte.  We hypothesized that this poising would have been greatly assisted by 
the development of computational algorithms to better determine the relationship 
between design and activity.  Nonetheless, the data we derived from these and other 
constructs fed into additional studies. 
 
MATERIALS AND METHODS 
Oligonucleotides 
All oligonucleotides were from IDT (Corraville, IA). 5’ Iowa Black or 3’ 
Alexa532 were utilized as the quenching or fluorophore moiety (respectively). RNA 
aptamers were transcribed using AmpliScribe T7 high yield transcription kits (Epicentre, 
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Madison WI) from 300pmol dsDNA by first extending a pair of overlapping 
oligonucleotides with SuperScript II (Invitrogen, Carlsbad CA).  The oligonucleotide 
sequences utilized to transcribe the RNA are in Table 2.1, whereas the rest of the 
sequences are listed throughout the figures. The RNA was purified on an 8% denaturing 
polyacrylamide gel.  Strand concentrations were detected by UV spectroscopy at 260nm 
on a Nanodrop ND-1000 (Wilmington, DE) using extinction coefficients and stock 
concentrations were  adjusted to 10uM for each oligonucleotide.  
Melting temperatures were predicted using OligoAnalyzer available from IDT at: 
http://www.idtdna.com/analyzer/Applications/OligoAnalyzer/. 
Activation and Binding Assays 
Activation assays were performed by combining the three oligonucleotides in a 
1:2:4 ratio (200nM fluorophore: 400nM aptamer: 1200nM quencher) in signaling buffer 
(DNA anti-ricin aptamer buffer: 20mM HEPES pH 7.35, 120mM NaCl, 5mM KCl, 1mM 
CaCl2, 1mM MgCl2; RNA anti-Ricin aptamer buffer: 1X phosphate-buffered saline, 5mM 
MgCl2; RNA anti-Yop51 aptamer buffer: 20 mM Tris pH 7.6, 150mM NaCl, 5mM 
MgCl2, 1mM dithiothreitol).  This ratio was chosen in order to reduce background signal 
that may have been caused by free fluorescently-labeled oligonucleotides.  The mixture 
was heat-denatured at 65°C for 3 minutes, then equilibrated at room temperature for 10 
minutes.  Assasys were carried out in Corning 96 well ½ area black opaque plates 
(Corning, NY).  Maximum fluorescence was measured in the absence of quencher oligo 
for each assay. 
Aptamers were assayed for activation in the presence or absence of ligand 
(1.33uM ricin A-chain: Sigma, St. Louis, MO or 1uM tyrosine phosphatase Yop51*: 
New England Biolabs, Beverly, MA) on a BioTek Synergy HT fluorescent plate reader 
(Winooski, VT) using the filter sets Ex 516/Em 575 and room temperatures between 
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25.7° C and 26.8° C.  The gain was automatically set in each assay such that a buffer 
blank yielded a signal of 26 RFU. Activation reaction was monitored at ten minute 
increments for one hour.   
Binding assays were performed as previously published (Hesselberth, Miller et al. 
2000).  Briefly, 200nM aptamer or aptamer plus equimolar concentration of protein was 
incubated in 100uL reaction with 1X signaling buffer for 30 minutes.  Binding and non-
binding aptamers were separated on a 0.45um HAWP filter (Millipore, Bedford, MA) 
and washed with 3 volumes of signaling buffer.  Non-binding aptamers were captured on 
nylon filters (Amersham Biosciences, Piscataway, NJ).  When fluorescent or quencher 
oligonucleotides were utilizedd, the ratio was consistent with activation assays.  Percent 
binding was measured by subtracting background filter signal and dividing signal present 
on the HAWP filter (bound RNA) with combined signal from both the HAWP and nylon 
filters (total RNA). 
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Aptamers and ribozymes can be adapted to serve as biosensors by a variety of 
methods (Breaker 2002; Silverman 2003; Verma, Jager et al. 2003; Nutiu and Li 2005).  
Most of these methods rely upon the aptamer or ribozyme undergoing a ligand-dependent 
conformational change.  A number of authors have generated aptamer beacons in which a 
non-native conformation is established by base-pairing, and the cognate ligand then 
stabilizes the native conformation (Stojanovic, de Prada et al. 2001; Fang, Sen et al. 
2003).  Ligand-dependent changes between non-native and native conformations can be 
read out by appending reporter molecules to the aptamer; for example, some aptamer 
beacons are hairpin stem structures in which a fluorophore and quencher are aligned in 
the non-native conformation, and split apart upon ligand-binding and conformational 
rearrangement, leading to fluorescence (Hamaguchi, Ellington et al. 2001). 
Ligand-dependent conformational changes can also be introduced into ribozymes 
by design or by selection, yielding allosteric ribozymes (so-called aptazymes).  For 
example, an aptamer that undergoes a flavin mononucleotide (FMN) dependent 
conformational change was appended to a hammerhead ribozyme; ligand-binding yielded 
a coupled change in the conformation of the active site and a concomitant increase or 
decrease in catalytic activity (Soukup and Breaker 1999).  Selections for RNA or DNA 
catalysis can also be designed in which the only successful catalysts will be those that can 
be activated by or utilize an introduced effector molecule (Roth and Breaker 2004). 
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To date, though, almost all of these aptamer and aptazyme biosensors have been 
generated by empirical design (Tang and Breaker 1997) or in vitro selection (Soukup and 
Breaker 1999; Robertson, Knudsen et al. 2004; Nutiu and Li 2005).  However, algorithms 
for the prediction of nucleic acid secondary structure have advanced to the point where 
nucleic acid secondary structures can be rapidly enumerated based on nucleic acid 
sequence (Hofacker, Fontana et al. 1994; Zuker 2000).  Likewise, probabilistic methods 
have been developed to sample populations of possible secondary structures and to 
predict structural stability (McCaskill 1990; Ding and Lawrence 2003).  There have also 
been theoretical treatments of what computational design criteria will maximize 
sensitivity and specificity in nucleic acid sensors (Dirks, Lin et al. 2004).  Therefore, it 
should be possible to develop algorithms for predicting the sequences of aptamers or 
aptazymes that will undergo ligand-dependent conformational changes and therefore 
function effectively as biosensors.   
The Breaker lab has developed a computational method for developing allosteric 
ribozymes activated by nucleic acid sequences (Penchovsky and Breaker 2005).  In their 
work, a virtual pool of RNA molecules was created that contained a randomized region 
inserted into the middle of the hammerhead ribozyme.  An algorithm was then used to 
predict the dominant secondary structures in the presence and absence of an 
oligonucleotide effector that was complementary to a given sequence in the randomized 
region.  For example, using this algorithm it proved possible to predict the sequence of 
ribozymes that would be inactive in the absence of an oligonucleotide effector (due to 
internal pairings that disrupted the ribozymes), and then would undergo structural 
rearrangement in the presence of the oligonucleotide effector returning the ribozymes to 
their native structures.  However, computational methods have not been applied to the 
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more difficult problem of controlling nucleic acid conformational change by non-nucleic 
acid effectors.  
In order to develop prediction methods for nucleic acid biosensors activated by 
analytes other than oligonucleotides, we wished to first explore a conformational 
transition that was reasonably well understood and that was computationally tractable.  
Breaker and co-workers had originally selected flavin-dependent hammerhead aptazymes 
from pools in which the joining region between an anti-flavin aptamer and the core 
catalytic domain of the hammerhead ribozyme were randomized (Soukup and Breaker 
1999)  At least one class of flavin-dependent hammerhead aptazymes was hypothesized 
to undergo a ‘slip structure’ conformational change in which the two strands of the 
joining region between the aptamer and the ribozyme realigned themselves (‘changed 
register’) upon the addition of flavin (Figure 3.1A).   
Herein, we describe the development of an algorithm for assessing the slip 
structure model, and the application of this algorithm to both designed aptazymes and 
designed aptamer beacons.  Computational automation of the algorithm should allow the 
structures and minimum free energies of millions of different sequences to be computed 
in hours on a typical desktop computer.  We have validated the utility of the algorithm by 
experimentally assaying a number of predicted constructs.  In general, the model 
performs as well or better than empirical design, identifying aptazymes that are activated 
by up to 60-fold by small organic ligands and aptamer beacons that are activated by up to 







Figure 3.1.  Energetic profile model of a slip structure.  a.b. Schematic of ‘slip 
structure’ activation.  In the absence of ligand (FMN or VegF), the joining region is 
trapped in an inactive conformation (red).  A structural rearrangement occurs upon 
ligand binding, shifting the joining region to the ‘active register’ (green) and 
potentiating either catalysis (cleavage site denoted by filled arrow in a.) or binding.  
c,d,e. Energetic profiles of three previously selected, FMN-responsive hammerhead 
aptazymes (Class I, Class III, and Class V respectively).  The free energies of 
folding (ΔGfold) in the absence of ligand are plotted versus the register of the joining 
region.  Position ‘0’ (vertical line) denotes the ‘active’ register of the ribozyme.  
The dashed line in c is a hypothetical energetic profile following ligand-binding. 
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RESULTS AND DISCUSSION 
Development and computational assessment of the slip structure model 
Aptazymes have been designed and selected in which ligand-binding aptamer 
domains are connected to the catalytic domain via a stem or ‘joining region.’  Breaker 
and co-workers have previously postulated that for some aptazymes the mechanism of 
activation involves a ‘slip structure’ in which ligand-binding induces a local reorientation 
of a stem and a corresponding change in ribozyme activity.  The slip structure model 
tacitly assumes that there are at least two conformational states for an aptazyme:  an 
unliganded, inactive conformer in which the joining region was ‘out-of-register,’ and a 
liganded, active conformer in which the joining region was ‘in register.’  In this model, 
the actual conformational change between the two structures could involve sequential 
changes in register:  the stepwise movement of one strand of a joining region relative to 
the other (Figure 3.1A). 
In order to assess whether there might be one or more stable, out-of-register 
conformers for previously selected FMN-aptazymes, we constructed a plot of the Gibbs 
energy of folding (ΔGfold) for each possible base-pair register within their joining regions 
(Figure 3.1C, D, E).  An ‘active register’ (denoted ‘0’) was first defined based on the 
known secondary structure of the hammerhead ribozyme.  All conformations near the 
active register were then computationally generated by simply shifting the lower (5’-
most) strand of the joining region relative to the upper (3’-most) strand, and determining 
the predicted folding energy at each register (see also Figure 3.6).  Conceptually, the 
energetic profiles that were generated describe the changes in free energy that the 
aptazymes would undergo as they ‘slipped’ from one register to the next.   
The free energy profiles generated for the different flavin-activated hammerhead 
aptazymes are consistent with activation via a slip structure mechanism.   In the 
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previously selected Class I aptazyme one strand of the joining region (CCUU) is 
predicted to base-pair with a complementary portion of the anti-FMN aptamer (Figure 
3.1A).  The assumption of this ‘inactive register’ effectively disrupts the structure of both 
the hammerhead and the anti-FMN aptamer (Fan, Suri et al. 1996).  The free energy of 
flavin-binding would stabilize the formation of a different stem structure containing only 
two Watson-Crick base-pairs in the joining region.  In this ‘active register’ aptamer 
residues important for flavin-binding (such as the terminal A-G pairing, Fan, Suri et al. 
1996) would no longer be sequestered and the hammerhead ribozyme could in turn 
assume an active conformation.  The energetic profiles of two other flavin-activated 
hammerhead aptazymes with different joining regions (Class III and Class V) were also 
constructed.  As was the case with the Class I aptazyme, out-of-active-register free 
energy minima were observed (Figures 3.1D, E).  The free energy of FMN binding to the 
aptamer (-8.6 kcal/mol) is more than enough to overcome the predicted energetic 
differences between the active and inactive registers.  
The prediction that there are active and inactive registers is consistent with the 
available structural data.  A hammerhead aptazyme that contained an anti-FMN aptamer 
and a Class I communication module was probed using an ‘in-line assay’ that exploited 
conformation-dependent differences in hydrolysis (Soukup and Breaker 1999; Jose, 
Soukup et al. 2001).  Flexible residues, such as those not ensconced in helices, show 
greater cleavage activity than residues that retain a fixed conformation.  The residues that 
we predict to be unpaired in the unliganded, inactive register were in fact cleaved (see 
figure 4 in Jose, Soukup et al. 2001).  Conversely, these residues should assume a more 
stable conformation in the liganded, active register, and the cleavage patterns were found 
to be correspondingly suppressed.   
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The predicted free energy profiles are not only consistent with activation via a slip 
structure mechanism, but could also account for the relative levels of activation.  The 
Class I aptazyme was predicted to have the greatest energetic separation between the 
stable active and inactive registers at nearly 7 kcal/mol (Figure 3.1C), and also showed 
the greatest effector-activation.  Class III and Class V have smaller predicted energy 
barriers of 4 kcal/mol and 2.5 kcal/mol respectively, and exhibited correspondingly 
smaller activations.  Both the height of the energy barrier and the distance between the 
stable inactive register and the less stable active register may affect the level of aptazyme 
activation.   
To further validate the utility of using energetic descriptions for slip structure 
mechanisms, energetic profiles for previously selected hammerhead aptazymes (Soukup 
and Breaker 1999) that were inhibited rather than activated by FMN were constructed 
(data not shown).  As expected, there were energetic minima at the active registers and 
less stable structures in adjacent registers; in other words, the predicted energy profiles 
were the converse of the energetic profiles predicted for flavin-activated aptazymes.  
Presumably, FMN-binding leads to a reorganization of the joining region such that an 
inactive register becomes favored relative to the active register. 
Computational selection of allosteric ribozymes 
To the extent that the slip structure model can be used to explain the activation 
parameters of known hammerhead aptazymes, it should prove possible to use this model 
to predict the sequences of new hammerhead aptazymes.  To this end, we developed a 
simple algorithm to select slip structure aptazymes from computationally-generated 
random sequence populations.  Energetic profiles similar to those shown in Figure 3.1 
were computed for each member of a pool in which the hammerhead ribozyme was 
joined to the anti-FMN aptamer via a symmetric N3-N3 joining region (46 = 4,096 
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variants; Figure 3.2A).  The energetic profiles of each candidate in the pool were 
compared to a reference energetic profile of a known hammerhead aptazyme (Class VI; 
Figure 3.2A, blue line).  Aptazyme variants that had similar energy profiles to the Class 
VI hammerhead aptazyme were selected for further analysis.  A total of 23 candidate 
aptazyme sequences were chosen that most closely matched the energy profile Class VI 
aptazyme; the energetic profiles of two of these aptazymes are shown in Figure 3.2A.  
These energy profiles differed substantially from the norm.  The black line in Figure 
3.2A corresponds to the average energetic composition of the un-selected pool.  
Figure 3.2.  Computationally selected hammerhead aptazyme variants.  a. The 
energetic profiles of every member of a pool in which an anti-flavin aptamer was 
joined to the hammerhead ribozyme via a symmetric, N3-N3 stem were compared 
to a reference energy profile (Class VI hammerhead aptazyme, blue line).  The 
average energetic profile and distribution (error bars) of the pool are shown in 
black.  The energetic profiles of two candidate aptazymes are shown in green 
(aptazyme c23) and red (aptazyme c52).  b. Activity assays with selected variants.  
Cleavage as a function of time following the addition of flavin was analyzed by 
polyacrylamide gel electrophoresis.  Non-specific activation by theophylline (Theo) 
was also monitored.  The sequences of the joining regions for the aptazymes and 
the calculated levels of activation in the presence of FMN are listed to the right. 
All 23 designed aptazymes were synthesized and the aptazyme variants were 
assayed in vitro.  Since these aptazymes were predicted to structurally rearrange from an 
inactive to an active conformation only in the presence of effector, they should show 
substantially greater cleavage activity only in the presence of FMN.  Three variants 
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exhibited greater than 4-fold activation in the presence of FMN (Table 3.1), and two of 
these, c23 and c52, exhibited activations (kobs+ / kobs-) of 21- and 60-fold, respectively 
(Figure 3.2B).  Of the remaining aptazymes eight were constitutively inactive and twelve 
were constitutively active. 
A control was carried out in which 23 aptazyme variants were selected at random 
from the population.  Three were slightly activated by FMN, although the best variant 
was activated only 5-fold (Table 3.1), as compared with over 20-fold for the 
computationally selected aptazymes.  In addition, five of the randomly selected aptazyme 
variants were found to be inactivated by FMN, whereas no computationally selected 
aptazymes were inactivated. 
 
Table 3.1.  Summary of computationally identified and experimentally tested 
aptazymes. 
HH = Hammerhead 
a  ‘Register’ indicates the required distance between the stable active and inactive 
registers. This distance could vary up to 2 positions in the algorithm, as stated in 
Figure 3.2. 
b  ‘Off’indicates ribozymes that were found to be constitutively inactive. 
c  ‘On’ indicates ribozymes that were found to be constitutively active. 
d  ‘Identified’ gives the number of ribozymes picked by the algorithm. 
e ‘Tested’ gives the number of ribozymes synthesized and assayed. 
 











N3-N3 HH FMN Random n/a 3 12 3 5 - 23 
N3-N3 HH FMN Selected -4 8 12 3 0 23 23 
N3-N3 HH Theo Selected (1) -4 0 3 1 0 4 4 
N3-N3 HH Theo Selected (2) -8 4 19 1 0 44 24 
N4-N4 HH Theo Random n/a 3 7 0 0 - 10 
N4-N4 HH Theo Selected -8 17 8 2 0 48 27 
N5-N5 HH Theo Random n/a 4 6 0 0 - 10 
N5-N5 HH Theo Selected -8 23 1 1 0 11,637 (68) 25 
N3-N3 Hairpin FMN Selected -4 12 0 1 0 13 13 
N5-N5 HH FMN Selected n/a 12 1 2 0 8,607 15 
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Varying the aptamer sensor domain 
Some joining regions identified by in vitro selection experiments have been 
shown to act as ‘communication modules’ that can lead to the activation of ribozymes by 
many different aptamers (Soukup and Breaker 1999).  We therefore replaced the anti-
flavin aptamer on the two best computationally selected aptazymes with an anti-
theophylline aptamer which should in turn alter the aptazyme’s effector specificity from 
FMN to theophylline.  One of the computationally-selected joining regions (c23) 
conferred roughly the same activation by theophylline (17-fold); the other joining region 
(c52) showed no activation. 
Given this success and the fact that theophylline-activated hammerhead 
aptazymes had previously been selected (Jenison, Gill et al. 1994; Soukup, Emilsson et 
al. 2000), the anti-theophylline aptamer was computationally appended to a N3-N3 pool, 
and the pool was sieved using energy parameters identical to those that had been used to 
identify flavin-dependent aptazymes.  Four other sequences were identified as candidate 
aptazymes, and were assayed for theophylline responsivity (Table 3.1).  A single variant 
from the four exhibited a 14-fold increase in rate upon the addition of theophylline.   
Varying the length of the joining region 
Since computational selections with short joining regions had proved successful, 
we were interested whether longer, more complex joining regions could also be sieved.  
The anti-theophylline aptamer was computationally joined to the hammerhead ribozyme 
by both N4-N4 or N5-N5 stems and the resultant pools were sieved using the slip 
structure energy model.  However, the distance between the active and inactive registers 
was changed from 2-4 to 4-8, reflecting the best-activated variants from the experimental 
N5-N5 selection (Table 3.1).  From the pool with a N4-N4 joining region 48 candidates 
were identified and 27 were experimentally assayed for self-cleavage in the presence of 
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theophylline.  However, from the pool containing a N5-N5 joining region, 11,637 
sequences (representing 1.1% of the original pool) were identified, despite the fact that 
the same parameter sets were utilized.  The complexity of this population was reduced by 
taking only one variant from selected sets whose 5’-most N5 regions were identical.  This 
left 68 candidate sequences, and 25 were experimentally assayed.  Two variants from the 
N4-N4 pool were found to be activated by theophylline (9- and 20-fold), and one clone 
from the N5-N5 pool was theophylline-responsive (16-fold).   
To again ensure that we had not identified aptazymes by chance alone, ten designs 
from the N4-N4 and N5-N5 pools were picked at random from these pools, synthesized, 
and assayed for activation in the presence of theophylline.  Not only were no effector-
dependent variants found, but the distribution of active and inactive variants was very 
different between the randomly selected and computationally sieved sequences (Table 
3.1).  The randomly selected sequences favored constitutively active variants, while the 
computationally sieved sequences contained many fewer constitutively active variants 
than inactive variants.   
Varying the ribozyme response domain 
While various aptamer domains could be easily interchanged using the slip 
structure model, we also wanted to test whether the same model could be generalized to 
other catalytic platforms.  The hairpin ribozyme was chosen as a candidate for 
engineering because like the hammerhead its structure also consisted of stacked helices 
(Rupert and Ferre-D'Amare 2001). 
The anti-FMN aptamer was appended to the end of loop B of the hairpin 
ribozyme via a symmetric N3-N3 random region, and 13 candidate aptazymes were 
identified using the same slip structure energy model that had proven successful for 
hammerhead aptazymes.  All 13 sequences were then assayed in vitro for their ability to 
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undergo cleavage in the presence of FMN.  A single sequence was found to be activated 
10-fold in the presence of FMN (Figure 3.3). 
 
Figure 3.3.  Computationally selected hairpin aptazyme variants.  a. The hairpin 
ribozyme (black, cleavage site marked with filled arrow) was modified with a 
randomized stem region (red) and an anti-FMN aptamer (blue).  Selection 
identified an aptazyme whose joining region facilitated activation in the presence of 
FMN.  b. Activity assay with the selected variant.  The filled and open arrows mark 
the positions of uncleaved and cleaved products, respectively. 
Computational selection of signaling aptamers 
Following up on our success using the slip structure energy model to 
computationally predict aptazyme sequences, we sought to use the model to generate 
conformation-switching aptamers that could be used as optical biosensors.  A non-
binding or inactive register was generated by manipulating the terminal stem of a hairpin-
like aptamer.  In the model, the addition of ligand should shift the register of the aptamer 
stem from the non-binding conformation to the original binding conformation.  Instead of 
detecting ligand-activated ribozyme cleavage, ligand-binding was coupled to structural 
changes that induced fluorescent signaling, much like a molecular beacon (Figure 3.1B).   
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We also attempted to extend the range of analytes that could activate 
computationally predicted biosensors from small organic molecules (such as theophylline 
and FMN) to proteins (such as vascular endothelial growth factor (VegF)).  A series of 
random sequence libraries of 4 to 9 residues in length (349,440 variants total) were 
created in silico and appended to the 3’ end of an anti-VegF aptamer 44T (Jellinek, Green 
et al. 1994).  We chose this aptamer because of the structural similarities to the FMN 
aptamer including a stem loop and internal bulge.  Minimum free energies were then 
calculated for each register of each member of the library.   
Since no VegF-activated aptamer beacon existed, no reference energy profile was 
available to sieve putative sequences from the library.  Therefore, we devised a set of 
criteria that could be sequentially applied (see also Figure 3.7):  (i) We first rank-ordered 
the sequences based on how well-defined the local minima were at the inactive register.  
Those aptamer beacons in which the free energy of folding at the inactive register 
differed most from the free energies of folding for the registers to either side were ranked 
most highly (see also Figure 3.4B).  By choosing well-defined local minima we hoped to 
reduce folding transitions in the absence of ligand and hence background signal (Flamm, 
Hofacker et al. 2001).  (ii) We then chose an energetic difference between the active and 
inactive registers that we hoped would lead to an increase in signal in the presence of 
ligand.  An arbitrary cutoff value of at least 3.5 kcal mol-1 energy difference between the 
active and inactive registers (ΔGfold, inactive - ΔGfold, active) was initially chosen.  This arbitrary 







Figure 3.4.  Design of a VegF-responsive aptamer beacon.  a. Following 
computational selection (as described in the text), four variants (44t.mab1-mab4) 
were identified from a N7 pool that had an energy minima at register 4.  The 
sequences of these variants are shown, along with two negative controls (44t.N7A 
and Rand.mab1).  The aptamer beacon 44t.mab1 was used in experimental studies.  
The randomized region of 44t.mab1 is shown in red, and residues in other aptamer 
beacons that differ from 44t.mab1 are shown in blue.  b. Energetic profiles for 
selected aptamer beacons.  In addition to the energetic profiles for 44t.mab1-mab4 
and 44t.N7A, the average energetic profile of all 16,384 variants is shown in black 
with error bars representing the standard deviation.  c. Sensitivity and selectivity 
assays of the designed aptamer beacon.  The aptamer beacon 44t.mba1 (2 μΜ) was 
assayed at four VegF concentrations and with 4 other proteins involved in 
angiogenesis (concentrations shown).  Also, negative controls were assayed with 
VegF (238 nM).  These experiments were performed in 30 μL reactions on an MJ 
Opticon at 37o C.  VegF-responsive aptamer beacons were at 2 μM final 
concentration and readings were taken after 60 minutes 
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Based on these criteria, no variants from the N4, N5 or N6 pools were predicted 
to function as aptamer beacons.  A total of 7 sequences were selected from the N7 pool 
(Figure 3.4A), 58 from the N8 pool, and 514 from the N9 pool.  The increase in 
predicted active variants roughly corresponds to the increase in pool complexity.  In 
general, we found that the largest energy differences between the active and inactive 
registers (criterion (ii), above) did not exceed 7 kcal mol-1 (ΔGfold, inactive - ΔGfold, active).  This 
energy difference should have been more than adequate for conformational transduction, 
as the binding energy for VegF has been measured to be -12.7 kcal mol-1 (Jellinek et al., 
1994). Because of the difficulties inherent in the synthesis of long, derivatized RNA 
molecules, we wished to choose a single variant that would have the best chance of 
showing ligand-dependent signaling.  Of the seven sequences chosen from the shortest, 
most synthetically accessible pool (N7), only four could form terminal base-pairings that 
would place fluorophores and quenchers adjacent to one another.  Of these four, 
44t.mab1 had the best-defined local minimum (criterion (i), ΔGfold = -5.97 kcal mol-1; 
Figure 3.4B); and had the second largest energetic differences between the active and 
inactive registers (criterion (ii),  ΔGfold, inactive - ΔGfold, active = 3.91 kcal mol-1); and also 
formed beacon like terminal base pairs in the inactive conformer.   
We synthesized 44t.mab1 as an aptamer beacon with fluorescein and DABCYL 
incorporated at the 5’ and 3’ ends, respectively.  In the absence of VegF, the aptamer 
should form a structure in which DABCYL quenches the fluorescein, while in the 
presence of VegF the aptamer should form a structure in which fluorescence is not 
quenched.  The computationally predicted signaling aptamer was activated 10-fold by 
238 nM VegF (Figure 3.4C), and displayed optimum activity at 37o C (data not shown).  
These results were especially impressive considering that other experimentalists have 
observed only 3- to 4-fold activation at similar protein concentrations when examining 
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similar constructs designed ‘by hand’ (Nutiu and Li, 2003).  The aptamer beacon was 
both sensitive and selective for VegF.  The beacon displayed a two-fold fluorescence 
increase at analyte concentrations as low a 24 nM (1 μg ml-1), and was not activated by 
non-cognate growth factors including PDGF, bFGF, or angiogenin (Figure 3.4C).   
The kinetics of conformational change and activation were, however, relatively 
slow:  it took 15 minutes to reach 50% activation and about 75 minutes to reach full 
activation (data not shown).  The kinetics of activation are consistent with a model in 
which the rearrangement of the engineered stem precedes protein binding.  The observed 
responsivity is comparable to the typical time required for the development of signals 
from protein-binding aptamer microarrays and much faster than the time required for 
antibody microarrays that typically require complicated post-binding procedures (such as 
the binding of secondary reagents in sandwiches and wash steps (Collett, Cho et al. 
2005)).  Thus designed signaling aptamers should be compatible with high-throughput, 
chip-based analyses.  
Mutational analysis of the computationally designed signaling aptamer 
To better assess how the selection criteria related to experimental performance, 
we rationally introduced mutations into the VegF signaling aptamer that were predicted 
to either stabilize or destabilize the inactive conformer (Figure 3.5A).  As can be seen in 
Figure 3.5B, stabilizing mutations had no affect on activation, suggesting that the criteria 
used for the selection of the inactive register overpredicted stability.  Consistent with this 
interpretation, the destabilizing mutations increased specific activation from 
approximately 1.5-fold at low (40 nM) protein concentrations to 3-fold (Figure 3.5B).  
As expected, the destabilizing mutations also increased background fluorescence (pre-
formation of the active conformer) prior to protein addition.  The initial successes of the 
slip structure model now provide a basis for further determining how systematically 
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varying the free energy parameters for computationally-derived biosensors affects their 
overall performance.   
 
Figure 3.5.  Modulating the performance of the VegF-responsive aptamer beacon.  
a. A series of predicted stabilizing (44t.mut1-2) or destabilizing mutations 
(44t.mut3-4) of 44t.mab1 were designed.  The randomized region of 44t.mab1 is 
red, and mutational changes are green.  b. Observed fluorescence (RFU) of 
44t.mab1 and its mutations with various angiogenesis proteins.  c. Same results as 
(b), but represented in terms of fold fluorescence increase in the presence of 
protein.  Reactions were carried out in TMK buffer on a Tecan Safire at 40o C.  




While in vitro selection methods are extremely robust, the ability to use 
computational design methods for the generation of biosensors would be extremely 
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valuable for a variety of reasons.  First, the ability to design nucleic acid biosensors 
further validates the utility of methods used for the computational prediction of nucleic 
acid secondary structures.  In particular, by showing that a slip structural model accords 
with both computational predictions and experimental data it may prove possible to use 
similar models to better understand conformational transitions in both natural and 
selected functional nucleic acids.  Second, computational selection should be inherently 
faster than experimental selection methods, and thus the time and effort required for the 
development of biosensors may be greatly decreased.  Based on the methods described in 
this paper, only a few sequences had to be synthesized and assayed to identify functional 
biosensors, while following selection experiments numerous different sequences typically 
have to be selected, characterized, and screened for their ability to function as biosensors.  
Ultimately, the computational sieving algorithm can be employed within hours to quickly 
generate a set of aptazymes or aptamer beacons corresponding to any of the large number 
of aptamers that have already been found.  Coupled with high-throughput, chip-based 
nucleic acid synthesis (McGall and Fidanza 2001; Nuwaysir, Huang et al. 2002) it may 
therefore prove possible to rapidly generate biosensor chips for the detection of multiple 
analytes.  Lastly, to the extent that computational models match experimental results, it 
should be possible to finely control the design process, generating biosensors with 
optimal sensitivities, signal-to-noise ratios, and dynamic ranges.   
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METHODS AND MATERIALS  
Computational methods 
The free energies of RNA secondary structures were calculated using the 
ViennaRNA package (Hofacker, Fontana et al. 1994).  Scripts to automate the evaluation 
and comparison of RNA secondary structure profiles were coded in the scripting 
language Python (http://www.python.org/).  These programs first generated nucleic acid 
sequences containing randomized regions:  either a randomized joining region between 
an aptamer and a ribozyme, or a randomized region at one end of an aptamer.  For each 
sequence in the randomized population, the free energy of folding was calculated along a 
series of ‘registers,’ defined as sequential alignments of a randomized region with 
potential pairing partners in the native portions of an aptazyme or aptamer. Energetic 
profiles (free energies of folding versus register) were constructed based on these 
calculations.  A flowchart that describes the computational selection of aptazymes is 




Figure 3.6.  Flowchart for computational selection of aptazymes. The sequences of 
all members of a pool spanning the joining region between aptamer and aptazyme 
were computationally generated.  To construct free energy profiles, the ‘register’ of 
one strand in the joining region was fixed relative to the other, and ΔGfold was 
calculated.  The register was then moved by one residue and the ΔGfold was again 
calculated.  The free energy profile (ΔGfold versus register) of each aptazyme was 
compared with a reference profile generated from an experimentally validated 
hammerhead aptazyme (Class VI).  To compare the energetic profiles of the 
aptazymes chosen by the algorithm (‘Identified,’ Table 3.1) two criteria were used:  
a. the register difference (2-4 in the N3 N3 pool and increased based on pool size), 
and b. the energetic difference between the minimums.  Except for the N5-N5 
selection described in the text, relatively few sequences were sieved from 
computationally generated populations based on these parameters. 
The aptazyme variants that best matched a defined profile were selected for 
further study.  For example, the calculated energetic profiles were compared to the 
energetic profile of an experimentally-validated reference aptazyme.  Similarly, aptamer 
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beacons were rank-ordered based on a number of criteria garnered from the in silico 
aptazyme selection (Figure 3.7). 
 
 
Figure 3.7.  Flowchart for computational selection of aptamer beacons.  Initially, 
the sequences of all members of a joining region pool were generated.  To construct 
profiles, the ‘register’ of the joining region was fixed and the ΔGfold was calculated.  
The register was then moved as in the aptazyme selection and the ΔGfold was again 
calculated.  A profile of ΔGfold versus register was constructed.  Aptamer beacon 
profiles were ranked and compared based on maximizing the isolation of the 
inactive register (ΔGfold of the inactive register relative to the registers to either side 
of it, i, in the Figure), and maximizing the energetic difference between the active 
and inactive registers (ii, in the Figure).  Except for the N8 and N9 selection, 
typically relatively few sequences were computationally sieved from the 
populations based on these parameters. 
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In vitro transcription of aptazymes 
Double-stranded DNA templates used for transcription were made by primer 
extension of complementary, synthetic DNA oligonucleotides (IDT, Coralville, IA).  
Radiolabeled RNA was generated by in vitro transcription using T7 RNA polymerase 
with trace amounts of [α-32P] UTP (Perkin-Elmer, Boston, MA), followed by purification 
on 10% denaturing polyacrylamide gels. 
 
RNA synthesis of aptamer beacons 
RNA was synthesized on an Expedite 8909 DNA synthesizer (PE Biosystems, 
Foster City, CA) using standard phosphoramidite chemistry.  3'-DABCYL (4-(4-
dimethylaminophenylazo)benzoic acid) and 5'-Fluorescein (6-FAM) were added using a 
fluorescein phosphoramidite and a 3'-DABCYL controlled pore glass (CPG) column, 
respectively.  All synthesis reagents were purchased from Glen Research (Sterling, 
Virginia).  Products were purified by reverse phase chromatography or on denaturing 
polyacrylamide gels.  The concentrations of aptamer beacons were determined based on 
their calculated extinction coefficients. 
 
Aptazyme assays 
Radiolabeled RNAs (20 pmoles) were thermally equilibrated by denaturation at 
70° C in water followed by cooling to room temperature.  Buffer (50 mM Tris-HCl, pH 
7.5, 20 mM MgCl2, final concentration) and ligand (FMN at 200 μM, theophylline at 1 
mM, or ATP at 1 mM).  Reactions (20 μL) were carried out at room temperature, and 
aliquots were removed at various time points and quenched in stop dye (85% formamide, 
0.01% bromophenol blue, 0.01% xylene cyanol and 60 mM EDTA, pH 8.0).  Uncleaved 
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and cleaved ribozymes were separated on 8% denaturing polyacrylamide gels, and 
radiolabeled bands were quantitated using a PhosphorImager (Molecular Dynamics, 
Sunnyvale, CA).  Rate constants were calculated by plotting the negative natural 
logarithm of the fraction of uncleaved ribozyme versus time, and determining the slope of 
a line fitted through at least three time points in the linear range of the assay.  Assays 
were repeated twice or more; observed levels of activation differed by less than two-fold. 
 
Aptamer Beacon assays 
Aptamer beacons (50 μM) in buffer (PBS [137 mM NaCl, 2.7 mM KCl, 4.3 mM 
Na2PO4*7H2O, 1.4 mM KH2PO4; pH 7.4] or TMK [100 mM Tris pH 7.5; 80 mM KOAc; 
10mM Mg(OAc)2]; 30 μL) were denatured  at 80o C for three minutes and cooled to room 
temperature over 5 to 15 minutes.  Either an MJ Research DNA Engine Opticon 
(Waltman, MA) with LED fluorescence excitation at 495 nm and photomultiplier tube 
(PMT) emission detection at 518 nm or a Tecan Safire (San Jose, CA) fluorescent 
monochrometer plate reader with excitation at 480/2 nm and emission detection at 520/2 
nm were used to assay aptamer beacons.  The thermal denaturation profiles for aptamer 
beacons were determined in the Opticon by obtaining fluorescence readings at 
temperatures from 25o C to 90o C in 1o C increments and with equilibration at each 
temperature for 1 min. 
 
In order to measure analyte activation, aptamer beacons were denatured as 
described above, then allowed to cool to room temperature over 10 minutes.  Aptamer 
beacons were then heated to 30o C in the Safire for 10 minutes, protein was added, and 
the fluorescence data was taken at two minute intervals for up to two hours.  The proteins 
assayed included recombinant human VegF (R&D Systems, Minneapolis, MN), 
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recombinant human bFGF (Bachem, King of Prussia, PA), recombinant human PDGF-
AB (R&D Systems, Minneapolis, MN), recombinant human angiogenin (Bachem), 
recombinant human MEK-1 (Santa Cruz Biotechnology, Santa Cruz, CA), glycosylated 
ricin A chain (Sigma Aldrich, St. Louis, MO), and bovine serum albumin (New England 
Biolabs, Ipswich, MA).  All proteins were initially reconstituted in the buffers described 
by their manufacturers.   
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One of the current limitations of signaling aptamer beacons is the lack of a signal 
amplification cascade upon binding.  Since aptamer beacons often display reduced 
binding to their targets compared with the originally selected aptamer (discussed below), 
detection limits are often reduced.  Signal amplification could be utilized to compensate 
for this limitation.  Typically, one aptamer beacon “signal” is related to one binding event 
and therefore detection is limited to ligand concentration and the sensitivity of the 
equipment utilized for detection.  A relatively recent and wholly unexplored type of 
signaling aptamer that may overcome this limitation is the assisted refold or antiswitch 
developed by Travis Bayer and colleagues with the anti-theophylline or anti-tetracycline 
aptamers (Figure 1.6A, E; Bayer and Smolke 2005).   
An antiswitch consists of three parts: a hairpin or antiswitch stem, an aptamer and 
a displacement stem.  The switch works by forming a stable conformer that traps or 
“hides” a sequence in a hairpin stem (Figure 1.6A in red) in the absence of ligand.  Upon 
the addition of ligand, the aptamer portion undergoes a conformational change, forming 
an active binding conformer in which the displacement stem (Figure 1.6A in blue) forces 
the hairpin into a single stranded state.  This free single stranded region is capable of 
performing a number of different tasks, including activating or inhibiting gene expression 
in vivo, as originally published.  It is also free to prime PCR or rolling circle 
amplification (Figure 1.6C; Yang, Fung et al. 2007).  Although untested, it could initiate 
a hybridization chain reaction originally developed by Dirks et al (Figure 1.6B; 2004).  
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We provide evidence of antiswitch conformational changes activating molecular beacons 
in this work (Figure 1.6D).  Additionally, the antiswitch could provide allostery for 
oligonucleotide dependent ribozymes (Figure 1.6F; Penchovsky and Breaker 2005), be 
utilized as fuel for DNA machines (Green, Lubrich et al. 2006) or form “toeholds” 
typically utilized in nucleic acid logic circuits (Kim, White et al. 2006; Seelig, 
Soloveichik et al. 2006).  Researchers have even begun to reversibly modulate enzyme 
activity through switchable aptamers and single stranded “removal strands” (Friedrichs 
and Simmel 2007).  The possibilities for ligand inducible regulation of single stranded 
DNA are vast, including application involving oligonucleotide activators. 
 
Figure 4.1.  Antiswitch based biosensor design.  A.) A conformational switch is 
induced by target (pentagon) binding, in which a sequence (blue) displaces a 
portion of the antiswitch hairpin (in red) making it available for various signaling 
pathways (B-F).  These pathways include B.) hybridization chain reaction, C.) 
rolling-circle amplification, D.) molecular beacon activation, E.) modulation of 
GFP expression in vivo and F.) ribozyme activity (cleavage denoted with carrot). 
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Theophylline Aptamer 
In the seminal work by Bayer et al, the well characterized anti-theophylline 
aptamer mTCT8-4 originally selected by Jenison and colleagues (1994) was utilized to 
activate or inhibit GFP or YFP production.  The affinity for theophylline (Kd = 0.29uM) 
is dependent on divalent metal ions including Mg2+, Mn2+ and Co2+ (Zimmermann, Wick 
et al. 2000) that help stabilize the RNA secondary structure (Jenison, Gill et al. 1994).  In 
addition, structural studies have been performed including computational three 
dimensional modeling (Tung, Oprea et al. 1996) and NMR techniques (Zimmermann, 
Jenison et al. 1997) that suggest a number of hydrogen bonds, Hoogsteen pairs and 
noncanonical base triplets help stabilize the tertiary structure.  In fact, theophylline 
interacts to form a base triplet with hydrogen bonds to both C22, U24 found in the upper 
internal loop (Figure 4.2B).  Stopped-flow fluorescent spectroscopy analyses have 
determined that the high binding affinity is due to a stabilization of the binding loop 
which significantly decreases the dissociation rate (Jucker, Phillips et al. 2003).  
Specificity, or the discrimination of closely related analytes is a hallmark of some 
aptamers.  For instance, the anti-L-arginine RNA aptamer displays 12,000 fold 
discrimination between L-arginine and its enantiomer D-arginine (Geiger, Burgstaller et 
al. 1996).  Likewise, there is a 10,000 fold difference in affinity between theophylline and 
caffeine by the anti-theophylline aptamer.  These two molecules differ only by a methyl 
group at the N7 position that is responsible for destabilizing the divalent metal binding 
loop of this aptamer (Figure 4.2; Zimmermann, Wick et al. 2000)..  
 79 
 
Figure 4.2.  Theophylline aptamer and derivatives.  A.) Chemical structures of 
caffeine and theophylline differing in the N7 methyl group (red box).  B.) 
Secondary structure of two aptamers that display high binding affinities for 
theophylline.   The blue box is the conserved aptamer sequence across a number of 
aptamer clones originally selected (Jenison et al).  The dashed boxes represent 
sequence differences between mTCT-8-4 and Δ-33.  The yellow colored bases are 
involved in non-covalent bonds with either theophylline (arrows) or represent 
noncanonical base pairs necessary for binding theophylline.  C32 is nonspecific and 
can be an A.  Base numbering is specific to Δ-33. Adapted from Zimmerman et al 
(1997). 
Theophylline biosensors 
With rational design it has proven possible to modulate various processes through 
the incorporation of a theophylline aptamer.  For instance, the aptamer was engineered to 
replace an RNA stem loop known to regulate tombusvirus replication leading to 
theophylline dependent viral titers (Wang and White 2007).  Conformational switching 
riboswitches capable of controlling gene expression in vivo have also been engineered to 
utilize the theophylline aptamer (Suess, Fink et al. 2004; Kim, Gusti et al. 2005).  
Riboswitches are different from the antiswitch because they work in cis, controlling 
expression from the mRNA sequence of the gene (Reviewed in Edwards, Klein et al. 
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2007).  Self cleaving (Tang and Breaker 1997; Soukup and Breaker 1999) or ligating 
(Robertson and Ellington 2000) ribozymes have been rationally engineered and 
experimentally selected to incorporate the theophylline aptamer for allosteric regulation.   
In addition fluorescent aptamer beacons have been designed around the 
theophylline aptamer.  The theophylline dependent ribozyme, created by Soukup and 
colleagues, was engineered to separate a fluorophore and quencher (Frauendorf and 
Jaschke 2001) upon cleavage.  Likewise, Stojanovic and colleagues created modular 
sensors using both a malachite green and theophylline aptamer (Figure 1.4C; 2004), in 
which dye binding was dependent on conformational changes induced through the 
binding of theophylline.  Similar to work presented here, a theophylline biosensor that 
activates a molecular beacon has previously been developed rationally (Rankin, Fuller et 
al. 2006), however the utility of our method is not to detect thrombin, but rather a study 
of the energetics involved in and the generation of generic antiswitches.  
Whereas it is generally difficult to model aptamer ligand interactions a priori, due 
to noncanonical base pairs and unusual structural motifs often found in aptamer ligand 
interactions (Feigon, Dieckmann et al. 1996; Patel 1997), through computational RNA 
structure prediction, we were able to search vast sequence libraries for known structural 
motifs.  Using ViennaRNA (Hofacker 2003) and Perl scripts we have computationally 
created and sieved a pool of random hairpins with unique sequence composition and 
length that, when appended to the theophylline aptamer, were capable of activating 
molecular beacons experimentally in the presence of theophylline.  We also show that 
tuning either the beacon or aptamer thermodynamic parameters provides higher signal to 
noise ratios and increased kinetic rates of activation.  It appears that the binding of the 
antiswitch to theophylline and consequently the molecular beacon irreversibly stabilizes 
the antiswitch into an “active” conformation even upon the dissociation of theophylline.  
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RESULTS AND DISCUSSION 
Development and computational assessment of the antiswitch model 
In an attempt to create a modular system for the development of signaling 
aptamers, we chose to model an antiswitch originally designed and published Bayer and 
colleagues whereby the binding of a cognate analyte (theophylline) induces a switch 
stabilizing the 3’ stem of the aptamer and denaturing the 5’ stem.  This single stranded 5’ 
stem is then free to bind a target molecular beacon loop sequence Figure 4.3.  The 
antiswitch model tacitly assumes there are six possible conformational states the 
antiswitch and beacon could be within depending on the energetics and presence of 
theophylline or molecular beacon (Figure 4.3A-F).  These states are controlled by 
equilibrium constants for the conversion between states, and is specified by the relative 
energetic stabilities of each state and the binding of aptamer with analyte.   
The antiswitch starts in a stable equilibrium with a molecular beacon termed the 
inactive unbound “OFF” state since it cannot actively hybridize the molecular beacon or 
bind the target (Figure 4.3 A).  Through conformational switches induced in part by 
target and molecular beacon, the antiswtich can become active (capable of binding the 
molecular beacon; Figure 4.3B, C, E, F), bind the ligand, (bound, Figure 4.3D, E, F) 
and hybridize to the beacon, which subsequently increases the fluorescent signal (“ON”, 
Figure 4.3C, F).  It is necessary to design an antiswitch, in which the inactive conformer 
is stable when a molecular beacon is present so hybridization doesn’t significantly drive 
the equilibrium to the active “ON” conformation independent of ligand binding. An 
antiswitch that posses an overly stable inactive conformer however, may not be capable 
of conformational switching upon ligand addition or assume sufficient alternate 
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conformations at equilibrium.  If however, the inactive unbound conformer is unstable 
and the active aptamer is most prevalent at equilibrium, then there will be high 
background.  In addition, if target binding does not drive the equilibrium towards an 
active state where the 5’ hairpin is open and available, then target depending signaling 
will not be detected. Ultimately, there must exist a coupled equilibrium between the 
antiswitch and the beacon that must be taken into account.   
 
 
Figure 4.3.  Kinetic pathways of Antiswitch activation by target binding and 
molecular beacon signaling.  The states are numbered in orange.  Starting in an 
inactive conformer (A) , the antiswitch should remain at equilibrium separate from 
a molecular beacon in the absence of target.  Upon ligand addition, a 
conformational change occurs in the antiswitch to the active conformer capable of 
binding both the target and the molecular beacon (F). 
To begin selecting new antiswitch constructs, we analyzed the energetics of the 
previously published antiswitch components to determine the parameters that may prove 
useful in switching.  Ultimately, the previous antiswitches maintained an inactive yet 
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stable structure in vivo and were capable of conformation switching into the active 
structure stabilized not only by the addition of theophylline (binding free energy = -8.96 
kcal/mol; Gouda, Kuntz et al. 2003) but also by hybridization to an area surrounding the 
AUG start codon of the mRNA expressing green fluorescent protein.  In this manner, 
GFP expression was dependent on theophylline availability and constitutively expressed 
in yeast (Figure 4.4).  
S1 was the original construct developed by Bayer et al which displayed switching 
in vivo at theophylline concentrations around 1mM.  When the 5’ antiswitch hairpin was 
destabilized (S4 construct), switching occurred at 100 fold lower theophylline 
concentrations.  However when the hairpin was stabilized, theophylline dependent 
switching didn’t change significantly from that of the original construct S1.  This 
suggests that S1 is actually quite stable within the in vivo system and destabilizing it may 
provide lower detection limits, increased speed or a favorable changes in background 
signal.  S1 was predicted to have a MFE with a ΔG of (-24 kcal/mol), yet destabilizing 
the 5’ loop decreased the overall free energy to -20.5 kcal/mol.  The core portion of the 
aptamer present in both the active and inactive structure has a minimum free energy of -
6.2 kcal/mol (Figure 4.4 purple box), whereas the 3’ antiswitch tail hybridizes with a 
portion of the 5’ hairpin in the active confomer possessing a minimum free energy of -
10.8 kcal/mol (Figure 4.4 blue sequence).   
The authors noted that the energy of the 3’ tail when bound in the active 
conformer (-10.8 kcal/mol) combined with the binding energy provided by theophylline 
(-8.9 kcal/mol) was identical to the folding energy of the 5’ hairpin (-17.8 kcal/mol).  In 
addition, we noticed that the destabilized antiswitch MFE of S4 (-20.5 kcal/mol) was 
nearly identical to the MFE of the aptamer structure in the active bound conformer (-20.2 
kcal/mol).  Bayer and colleagues also designed tetracycline dependent antiswitches.  We 
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compared the structural and energetic profiles within this group of antiswitches to the 
published in vivo expression levels and found similar correlations to the theophylline 
dependent antiswitches (data not shown).  
 
 
Figure 4.4.  S1 and S4 antiswitch activation by theophylline (pentagon T).  The 
MFE antiswitch is labeled in green.  The MFE for the 5’ hairpin is denoted with 
red.  The core aptamer is boxed in purple.  The core aptamer in the active bound 
conformer is boxed in blue.  The red and blue lines denote, in which the hairpins 
hybridize in the alternate conformer.  The active antiswitch binds to the AUG start 
codon of the GFP gene transformed into yeast cell line. The yellow highlighted 
bases represent differences between S1 and S4. 
Computational selection of antiswitches 
After assessing potential parameters from the published antiswitches, a 
computational selection was performed (see Materials and Methods) to determine 
potential antiswitches from a pool of random sequences.  We first developed a program 
(see Computational selection in Materials and Methods) to create a pool of random 
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sequence hairpins (Figure 4.5).  The pool size, hairpin length and loop size were all input 
variables.  The use of a 10,000 sequence pool often provided ample variation to selected 
representative variants within relatively short time frames (10 minutes to 3 hours 
depending on stem length).  Each random sequence was added to the pool array if it 
contained no internal structure or sequence runs (listed in Materials and Methods) until 
the pool reached the predefined size.  For the initial pool, a hairpin length of 15 
nucleotides was utilized.  If the sequence did not pass the tests, it was deleted and a new 
sequence was created.  Once the pool was complete, each member was converted into a 
hairpin by adding a loop sequence of CCUC and the reverse complement of the pool 
sequence.  The hairpin was also tested to verify it indeed formed the proper stem loop 
structure.  
Following this, the actual antiswitch was constructed by appending the hairpin to 
the 5’ portion of the aptamer sequence along with a 10 nucleotide 3’ tail of complement 
sequence and predefined length capable of hybridizing a portion of the hairpin.  We also 
searched the complete antiswitch sequence for repeats.  In addition the antiswitch was 
folded to determine if the proper MFE structure formed.  The MFE structure was defined 
as one, in which the 5’ hairpin (Figure 4.5, red box) and the core aptamer (Figure 4.4, 
purple box) formed, and the 3’ tail remained unpaired (Figure 4.5, blue sequence). 
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Figure 4.5.  Flowchart of computational selection. The MFE for the antiswitch 
present as the inactive unbound “OFF” conformer (green box) switches into a the 
active bound “ON” conformer (blue box) upon the addition of target (T hexagon) 
and molecular beacon.  The 5’ hairpin is boxed in red. 
Lastly free energy profiles of each pool member were calculated.  Those sequence 
variants, in which the minimum free energy difference between the hairpin (red box) and 
aptamer (blue box) were within a range of 2 and 3 kcal/mol, were kept.  Those members 
that fell outside this range were discarded (Figure 4.5).  In addition, we verified that the 
folding free energy of the antiswitch was less stable than the combination of the folding 
free energy of the active unbound “OFF” conformer and the binding energy provided by 
the ligand. 
Since S1 had an antiswitch stem length of 15 base pairs and a loop sequence 
consisting of “CCUC”, we started with these variables.  Also, we were uncertain whether 
a large or small difference between the inactive antiswitch structure and the active 
antiswitch structure was important so we chose a sequence representing a larger 
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difference  (similar to S1) to be certain that the inactive conformer would predominate at 
equilibrium. 
 











Bayer S1 74 4 15 9 -24.00 -20.20 -17.80 -3.80 -2.4 not active
Bayer S4 74 10 12 9 -20.50 -20.20 -14.30 -0.30 -5.9 2.1 fold
randpool AS1 75 4 15 10 -25.10 -21.00 -18.90 -4.10 -2.1 not active
1083 A6-10 63 4 10 11 -21.90 -19.00 -15.70 -2.90 -3.3 Slow, 3 fold
1083 A6-11 63 4 10 11 -23.10 -23.10 -16.90 0.00 -6.2 Fast, 1.5 fold
3454 A8-6 70 6 12 12 -22.80 -22.80 -16.60 0.00 -6.2 Fast, 2 fold
 
Table 4.1.  Energetics of the published antiswitches (S1 and S4) along with new 
designs (AS1, A6-10, A6-11, A8-6).    The colors are consistent with Figure 4.3 
and Figure 4.4.  
 
 
Figure 4.6. Energetic profile for a pool of antiswitches.  The sequences that 
conform to the parameters defined in (Materials and Methods) similar to S1 in a 
10,000 variant pool consisting of a 15-mer hairpin length with a 4 base pair loop 
and 9 bp 3’ tail.  The cutoff difference between the antiswitch and aptamer was 3 
kcal/mol. The previously selected antiswitch S1 is labeled with an arrow. 
From an original random pool of 10,000 variants that was winnowed down to 425 
members that conformed to the parameters, we selected one variant (AS1; Table 4.1) that 
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most closely matched the energetic profile of S1.  In addition two of the constructs 
published by Bayer and colleagues (S1 and S4; Table 4.1) were synthesized and tested 
for preliminary activation in vitro.  Since S1 showed relatively higher free energies 
compared to the other members of our in silico pool, AS1 was selected in this energetic 
area of the pool (Figure 4.6).  It should be noted that, the difference between the MFE of 
the active conformer and the minimum free energy of the inactive conformer is larger 
with S1 and AS1 compared to S4 (Table 4.1).  
We also designed two molecular beacons to detect theophylline dependent 
conformational switching of the antiswitch.  The first was similar a portion of the GFP 
5’UTR previously utilized (Bayer and Smolke 2005) and could hybridize with both S1 
and S4. The second was specific for AS1. 
AS1 theophylline dependent activation 
We synthesized and purified the variant (AS1) selected computationally along 
with Bayer’s antiswitches and the molecular beacons.  We then assayed fluorescent 
activation of the respective molecular beacon with each of the constructs (Figure 4.7A). 
Ligand-dependent fluorescence activation was measured by adding 250uM theophylline 
(100 fold higher than the published aptamer Kd) and the results were compared with 
activation data from S1 and the destabilizing mutant S4 (Figure 4.7A).  Unfortunatly, we 
could not detect theophylline dependent activation from either S1 or AS1,  however a 2.3 
fold signal increase was detected with S4.  This suggests that the inactive conformers of 
both AS1 and S1 are overly stable and cannot be switched into active conformers upon 
ligand addition.  In addition, S4 does not fully activate the beacon.  It could either be that 
the aptamer cannot bind due to the stability of the inactive conformer, or that binding 





Figure 4.7.  Molecular beacon based activation of assay of AS1, S1 and S4. A.) 
The fluorescent activation of AS1 (test) compared with a positive control, 
maximum and minimum signal is shown.  These are performed in conjunction with 
tests of S1 and S4 including the minimum and maximum beacon fluorescent.  
Concentrations of 600nM antiswitch, 300nM molecular beacon, 600nM activators, 
250uM theophylline 20 minutes at 37°C.  B.) Structural switching of AS1 with the 
beacon activator and the antiswitch AS1. 
Computational selection of A6-10, A6-11 and A8-6 
Whereas the previous set of antiswitches were validated by in vivo expression, we 
found the same constructs were unable to hybridize with a molecular beacon in vitro thus 
limiting their usefulness as reagentless diagnostics.  In addition, the parameters utilized 
for modeling AS1 around the energetics of S1 provided an antiswitch trapped in the 
inactive unbound conformer.  Therefore, we thermodynamically modeled three new 
antiswitch constructs with less stable 5’ hairpin energetics (Figure 4.8A and Table 4.1). 
We again tested these constructs in the presence of theophylline except we 
increased the concentration of theophylline, and utilized equimolar concentrations of 
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beacon and antiswitch instead of a two-fold difference before.  The beacon and antiswitch 
were incubated in the absence of theophylline until a stable equilibrium was achieved, 
then 1mM theophylline was added and the reaction was monitored at various time points 
over one hour (Figure 4.8B). 
It is apparent that the overall activation level is partially determined by the 
stability of the molecular beacon alone.  Both A6-10MB and A6-11MB have a predicted 
MFE of around -5.9 kcal/mol, whereas A8-6MB is much less stable at only -1.9 kcal/mol.  
When comparing the percent total signal of the beacons in the absence of antiswitch, A8-
6 has a predictably higher signal than either of the other two beacons.  The percent total 
signal is calculated by dividing the signal at each time point by the maximum possible 








Figure 4.8.  Prediction of functional antiswitches A6-10, A6-11 and A8-6.  A.) A 
structural model for antiswitch activation of three constructs with different 5’ 
hairpin sequences.  Similar color conventions are utilized.  B.) Activation assay 
showing activation over time.  Equimolar concentration of antiswitch and 
molecular bacon (500nM) were incubated with 1mM Theophylline (red, green 
yellow bars).  A6-10 slow, 2.1 fold activation.  A6-11 Fast but 1.5 fold activation.  
A8-6 Fast, 1.6 fold activation, beacon less stable. 
There also appears to be a correlation between the stability of the beacon bound to 
the antiswitch and the kinetic rate.  A6-11MB and A8-6MB have similar beacon 
hybridization free energies (-11.0 kcal/mol and -10.5 kcal/mol respectively) and fully 
activate within the three minutes between theophylline addition and the first fluorescence 
measurement as opposed to A6-10 and S4 (-16.9 kcal/mol and -17.4 kcal/mol), in which 
the signal was still increasing 60 minutes after theophylline incubation.   
Lastly, the data suggests that the stability of the 5’ hairpin in the inactive unbound 
antiswitch conformer affects the kinetic rate as suggested by previous results comparing 
S1 with S4.  This apparent difference in kinetic rates could be due to the relative 
stabilities within the antiswitch of A6-11 and A8-6 (Table 4.1) since there is no predicted 
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minimum free energy difference between the inactive unbound antiswitch and the 
aptamer portion of the active conformer. 
Specificity of A6-10 and A8-6 
We next wanted to determine how specific the antiswitch was for the target 
theophylline.  It has previously been shown that the unmodified aptamer can discriminate 
between theophylline and caffeine by up to 10,000 fold, yet the aptamer is capable of 
binding caffeine at relatively high ligand concentrations above 5mM (Figure 4.2; 
Zimmermann, Wick et al. 2000).  By incorporating the aptamer into an antiswitch, we 
wanted to verify that these changes didn’t interfere with ligand specificity.  We therefore 
tested the antiswitch constructs A6-10 and A8-6 for activation in the presence of ligand 
concentrations from 10nM to 1000nM (Figure 4.9).  As can be seen, there was relatively 
little additional fluorescence change in the presence of caffeine compared to no ligand.  
Surprising, however theophylline could be detected as low as 10uM even though this is 
much lower than the available antiswitch (500uM A6-10 and 250uM A8-6).  These 
results suggest that once inactive unbound antiswitch switches into an active conformer 
upon ligand binding, the active conformer becomes energetically trapped by hybridizing 




Figure 4.9.  Specificity of A6-10 and A8-6.  A.) A6-10 tested (500nM) at various 
concentrations of theophylline or caffeine and measured after 1.5 hours incubation.  
B.) A8-6 (200nM) assayed identically to A6-10. 
Improving kinetic response by changing the beacon energetics 
We wanted to determine whether we could increase the speed of activation 
through manipulation of the beacon alone.  Whereas A6-10 and the beacon A6-10MB 
displayed the highest fold activation, it proved the slowest to activate.  We realized that 
upon folding, the loop of A6-10MB was closed down by two stacking G:C base pairs.  
We therefore, designed two new beacons specific for A6-10 with larger hairpin loops, 




Figure 4.10.  Improving the kinetics of antiswitch activation.  A.) Two new 
beacons (green box and blue box) were assayed along with the previous beacon 
(red box) all specific to A6-10.  B.) Kinetic assay for the modified beacons.  Result 
colors matched the molecular beacon in (A).  The antiswitch and respective 
beacons were mixed at equimolar concentration (500nM) and assayed in the 
absence (open markers) or presence of 500uM theophylline (closed markers).  
Activation was normalized to the minimum signal (at time point 0) and maximum 
detectable signal upon ligand addition. 
The antiswitch was assayed with the three beacons separately over time in the 
presence of 500uM theophylline or caffeine (Figure 4.10B).  Again, in all cases, there 
was no difference between the addition of caffeine and the absence of target suggesting 
the antiswitch was specific for theophylline (data not shown).  The new beacon (A6-
10.8TMB) designed with the largest loop and least stable free energy (ΔG = -4.3 
kcal/mol) also provided the fastest activation signaling to maximum levels within 10 
minutes, whereas the other two beacons showed nearly identical kinetic rates taking 
nearly 2 hours to fully activate. 
 
 95 
CONCLUSIONS AND PROSPECTS 
We recently began work on this project and a number of experiments are still 
necessary.  For instance, we would like to test the limits of detection for theophylline. A 
substantial increase in fluorescence was observed from the addition of antiswitch alone 
(Figure 4.8B) and thus predicting antiswitches with more stable hairpins may be 
necessary to reduced background signal. 
Once the proper energetic parameters have been fully elucidated, we would like to 
detect more complex targets by incorporating aptamers capable of binding proteins or 
whole cells.  However based on results with anti-ricin and anti-yop51 aptamers, choosing 
an aptamer, in which the structure has been experimentally determined may be an 
important factor.  Lastly, much of the data must be reacquired to calculate statistical 
deviation. 
 
MATERIALS AND METHODS 
Synthesis and Purification 
Some of the initial constructs were ordered through IDT (Coralville, IA), whereas 
we synthesized other including all of the beacon activators and some of the molecular 
beacons.  We found no difference in experimental data between the two sources (data not 
shown) and only time or cost determined the source.  Materials were synthesized as in 
(Hall, Hesselberth et al. 2007).  Briefly 5’ 6-FAM moieties were introduced by 5’ 
phosphoramidite chemistry, whereas  3’ quenchers were incorporated through controlled 
pore glass (CPG) solid supports (Glen research, Sterling, VA) during synthesis.  The 
quenchers utilized include dabcyl (4-(4-dimethylaminophenylazo)benzoic acid) and 
Black Hole Quencher 1 (BHQ-1).  After deprotection samples were lyophilized and 
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purified by HPLC (Nutiu and Li 2003) with the following changes: column was an 
XTerra MS C18 Column with dimensions of 4.6mm x 30mm and 2.5um bead diameter.  
The two solvents were 0.1M TEAA and 100% acetonitrile on a nonlinear gradient from 
5% to 35% acetonitrile over 30 minutes at a flow rate of 3 mL/min.  We collected 2/3 of 
the main peak width showing absorption at both 260nm and 495nm.  The purified DNA 
was lyophilized and resuspended in 100ul diH2O.   
RNA aptamers were transcribed using AmpliScribe T7 high yield transcription 
kits (Epicentre, Madison WI) from 200pmol dsDNA by first extending a pair of 
overlapping oligonucleotides with SuperScript II (Invitrogen, Carlsbad CA).  The 
oligonucleotide sequences utilized for RNA production are listed in Table 4.2.  RNA was 
purified on an 8% denaturing polyacrylamide gel.  For all sequences, strand 
concentrations were detected by UV spectroscopy at 260nm on a Nanodrop ND-1000 
(Wilmington, DE) using extinction coefficients and adjusted to 10uM for each 
oligonucleotide sequence. 
Kinetic Assays 
Assays were performed with equimolar concentrations of beacon and RNA 
antiswitch (500nM) in 50ul reactions at room temperature unless otherwise specified.  
Briefly, the aniswitch and beacon were separately mixed in signaling buffer (100mM 
HEPES pH 7.3, 50mM NaCl, 5mM MgCl2 (Jenison, Gill et al. 1994)), heat denatured at 
60° C for 3 minutes, cooled to 25° C at 0.2° C/sec.  They were allowed to further 
thermally equilibrate at room temperature (26° C) for 5 to 15 minutes then mixed.  
Assays were carried out in Corning 96-well ½ area black opaque plates (Corning, NY).  
Maximum fluorescence was measured by hybridizing the beacon with an unmodified 
complement sequence, whereas minimum fluorescence was measured with the beacon 
alone.  Aptamers were assayed for activation in the presence or absence of 1mM 
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theophylline or caffeine (Sigma, St. Louis, MO) on a BioTek Synergy HT (Winooski, 
VT) fluorescent plate reader at between 25.7° C and 26.8° C with a gain of either 48 or 
50 such that a buffer blank yielded a signal of 26 RFU.   
Computational methods 
The free energies of RNA secondary structures were calculated using the 
ViennaRNA package (Hofacker, Fontana et al. 1994).  Scripts to automate the evaluation 
and comparison of RNA secondary structure profiles were coded in the scripting 
language Perl (http://www.perl.org/).  These programs first generated nucleic acid 
antiswitch sequences with randomized 5’ hairpins and 3’ tails.  For each sequence in the 
randomized population, the free energy of folding was calculated and the sequence was 
also compared to a list of sequence repeats (AAAA, GGGG, UUUU, CCCC, AUAUA, 
UAUAU, GCGCG, CGCGC, GUGUG, UGUGU, UUGGU, GGUUGAUAUU, UAUAA, 
AUUAA, UAAUU, AAUUA, UUAAU).  RNAfold was utilized with the following 
constraints: “noLonelyPairs” that removes one base pair loop energies from the 
calculation of minimum free energy, “d = 0” that similarly prevents dangle end energies, 
“tetra_loop” to incorporate known stable tetra loops, and “no_closingGU” such that a GU 
pair cannot close a loop.  All of these constraints were suggested in the ViennaRNA 



































Chapter 5: Kinetic optimization of a protein-responsive aptamer beacon 
 
INTRODUCTION 
Aptamers have proven to be useful as biosensors, in large measure because they 
can be readily adapted to a variety of sensor platforms and signal transduction schemes 
through the rational manipulation of their sequences and secondary structures (reviewed 
in Nutiu and Li 2005; Bunka and Stockley 2006; Deisingh 2006; Cho, Rajendran et al. In 
Press).  One highly generalizable scheme for the generation of so-called aptamer beacons 
involves generating antisense oligonucleotides that denature the functional structure of an 
aptamer, and then placing fluorescent reporters and quenchers on the sense and antisense 
strands (Nutiu and Li 2003).  Upon binding to a target ligand, the equilibrium between 
the antisense-bound, non-functional structure and the free functional structure is altered, 
with a concomitant change in observed fluorescence.  However, while this and other 
signal transduction schemes readily yield aptamer biosensors that can sensitively detect a 
variety of analytes, the kinetic properties of the resultant biosensors have not been 
examined in any detail. 
We have therefore generated a series of aptamer beacons that can detect the 
protein thrombin, and examined their kinetics of signaling.  While the anti-thrombin 
aptamer is generally chosen for biosensor development because of its simplicity, in this 
instance it was chosen in large measure because so many previous studies have used this 
aptamer.  The original thrombin aptamer was a ssDNA with a consensus sequence of  
GGtTGG(N2-5)GGtTGG (Bock, Griffin et al. 1992). It was not only the first time a 
ssDNA selection had successfully been completed, but the first time a target without 
native nucleic acid binding properties was shown to bind DNA.  In 1993, the structure of 
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the best aptamer d(GGTTGGTGTGGTTGG) was elucidated by two dimentional NMR 
(Macaya, Schultze et al. 1993) three dimentional NMR (Wang, McCurdy et al. 1993; 
Schultze, Macaya et al. 1994) and X-Ray crystallography (Padmanabhan, Padmanabhan 
et al. 1993).  These studies showed that the potassium dependent aptamer formed a 
unimolecular quadruplex in solution where two G-quartet stacks were connected by two 
T-T loops and a TGT loop (Figure 5.1A, black underlined).  They also found that the 
aptamer binding site overlaps with thrombin’s fibrinogen recognition exosite (FRE) along 
with the thrombin platelet receptor and thrombomodulin binding sites.   
Following this, both RNA (Kubik, Stephens et al. 1994) and additional DNA 
selections (Macaya, Waldron et al. 1995; Tsiang, Jain et al. 1995; Tasset, Kubik et al. 
1997) were completed. While each of the selected aptamers contained a G-quadruplex, 
the subsequent DNA selections suggested an additional four to seven base pair duplex 
could help stabilize the quadruplex and lower the binding affinity (Figure 5.1C vs 1A).  
It was also proposed by Macaya et al that this duplex could provide additional contacts 
with thrombin.  While the RNA aptamer was shown to bind thrombin’s heparin-binding 
exosite, all DNA aptamers other than those selected by Tasset et al bound the FRE.  
Tasset and colleagues selected a ssDNA aptamer termed 60-18 with the sequence 5’-
AGTCCGTGGTAGGGCAGGTTGGGGTGACT-3’ that displayed potassium 
independent binding similar to other aptamers with extended duplex (Figure 5.1C).  In 
contrast however, the bolded “TA” in the previous sequence was found through photo-
crosslinking experiments to direct the aptamer to the heparin-binding exosite while a TT 
loop directs the aptamer to the FRE site in previously selected DNA aptamers.  
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Figure 5.1.  Structure Switching Models. A.) Structure-switching reporter 
developed by Nutiu (2003).  Blue is Stem-1, purple is Stem-2, underlined sequence 
is the original DNA sequence consensus for the thrombin binding aptamer (Bock, 
Griffin et al. 1992), later called G15D (Tasset, Kubik et al. 1997). Green is FDNA1 
with a 5’-Fluorescein and dark red is QDNA6 with a 3’-DABCYL.  The G-quartet 
is drawn to represent three dimensional structural arrangement. B.) Representative 
activation of Apt4 (Stem-2) and Th.Q1 (QDNA6). C.) AptH complexed with Th.Q-
5-2.  AptH is derived from 60-18[29] (underlined; Tasset, Kubik et al. 1997) with 
TCAGCA appended to the 5’ end.  Similar sequence and color conventions are 
used where the green sequence is bound to a fluorescein, the red sequence 
represents a duplex stem in the aptamer conformer, grey is an internal bulge 
characteristic of this aptamer.   
Once the structure and functional characteristics of the thrombin aptamer were 
elucidated, rationally designed signaling biosensors were developed.  In 2001, 
Hamaguchi et al re-engineered the original thrombin aptamer selected by Bock et al to 
act as a signaling aptamer by including additional bases at the terminal 5’ end 
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complementary to those at the 3’ end (Hamaguchi, Ellington et al. 2001).  This sequence 
had a minimum free energy structure that formed a hairpin-loop akin to a molecular 
beacon in the absence of thrombin.  When thrombin was added, the G-quadruplex forced 
a global conformational rearrangement separating the fluoresecent moieties affixed to the 
5’ and 3’ ends.  It is interesting to note that the biosensor could switch structures quickly 
depending on the presence of divalent magnesium (beacon) or monovalent potassium (G-
quartet).  It was also shown that the thrombin aptamer could act as a FRET beacon 
without the additional sequence used by Hamaguchi et al (Li, Fang et al. 2002).  In the 
absence of thrombin the aptamer was generally unstructured thus separating fluorescein 
and DABCYL appended to the 5’ and 3’ ends, respectively.  Thrombin dependent 
structural stability allowed the terminal fluorophores to interact thus changing the 
fluorescent spectra.  
In an attempt to generalize the design of aptamer biosensors, Nutiu and Li 
developed both a tripartite and bipartite signaling aptamer (Nutiu and Li 2003).  They 
called this a “duplex-to-complex structure-switching approach,” whereby the global 
conformational changes characteristic of thrombin binding led to the displacement of a 
hybridized quencher oligo. The bipartite method was developed with the ATP aptamer 
5’-ACCTGGGGGAGTATTGCGGAGGAAGGT-3’ (Huizenga and Szostak 1995) was 
extended at the 5’end and a fluorephore was added, a secondary oligo with a quencher at 
the 3’end was designed to hybridize to the aptamer extension and disrupt the native 
aptamer structure in the absence of target (Figure 5.1A).  Once ATP was added, the 
aptamer would undergo a conformational change that would displace the quencher oligo.  
The tripartite method was used to design biosensors around the ATP and thrombin 
aptamers.  It is very similar to the bipartite model yet more modular.  Instead of 
modifying the aptamer with a fluorophore and using a quencher oligo, the aptamer has an 
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additional extension that is complementary an oligo with a fluorophore at it’s 5’ end. The 
complementary oligos are separated such that the labels are in close proximity.  Upon 
ligand binding, the quencher oligo is displaced, yet the fluorescinated oligo is left 
hybridized, thus yielding an increase in fluorescent signal.  Activation was measured both 
as a function of temperature and in varying magnesium concentrations.  The aptamer 
activated nearly instantaneously at 37C, yet was considerably slower at lower 
temperatures.  In addition to temperature variations, others have characterized binding 
kinetics as a function of pH, ionic strength and aptamer configuration using quartz crystal 
microbalance for detection.(Hianik, Ostatna et al. 2007).   Both aptamers were used in a 
proximity assay that allowed coassociation of the aptamers to bring together two 
“signaling oligonucleotides” thus producing a large change in FRET signal (Heyduk and 
Heyduk 2005). 
Herein, we developed two different bipartite thrombin signaling aptamers with 
fast activation rates at room temperature (25° C) and provided guidelines for the design 
of quencher oligos and requisite quencher moieties.  By examining the relationship 
between the design of biosensors based on the anti-thrombin aptamer and their response 
dynamics, we hoped to provide a foundation for the comparison and understanding of 
many different sensor platforms and methods. 
 
RESULTS AND DISCUSSION 
Designing aptamer beacons that signal the presence of thrombin 
Nutiu and Li (2003) have previously generated antisense displacement aptamer 
beacons for the detection of thrombin.  In this work, two antisense oligonucleotides 
containing fluorescent and quencher moieties were annealed to and thereby denatured a 
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short, anti-thrombin DNA aptamer known to form a quadruplex structure (Clone 29; 
Bock, Griffin et al. 1992).  Interaction with thrombin disfavors the tripartite, quenched 
complex and stabilizes the quadruplex structure, thus destabilizing the quencher 
oligonucleotide and yielding an increase in fluorescence (Figure 5.1A).  The Li group 
demonstrated that the beacon responded quickly (T1/2 = 1.2 min) at 37o C, but was 
considerably slower at room temperature. 
We have now used this displacement model to design additional aptamer beacon 
constructs.  However, we have altered the model so that the fluorescent label is 
incorporated directly at the 5' end of the aptamer.  In this way, only one antisense 
oligonucleotide is used to form the quenched, bipartite complex, and the release of this 
single inhibitor results immediately in a fluorescent signal (Figure 5.1B, 1C).  Since the 
only design variables for the two-piece constructs are the number and position of base-
pairs between the aptamer and the antisense quencher oligonucleotide their performance 
can be more readily predicted, engineered, and optimized. 
Optimizing quencher length for responsivity at room temperature 
In order to better understand how aptamer beacon signaling and kinetics might be 
optimized we attempted to develop a sensor that could be used conveniently at room 
temperature in real-time.  We first generated a series of aptamer beacons in which the 
number and positions of base-pairs between the antisense quencher oligonucleotide and 
the aptamer beacon were changed (Figure 5.2A; Apt4).  Apt4 was synthesized with a 
fluorescein at its 5’ end and a series of increasingly shorter antisense oligonucleotides 
were synthesized with DABCYL at their 3’ ends.  It was hypothesized that the shorterer 
quencher oligonucleotides would form less stable complexes, and thus might activate 
more quickly at room temperature.   
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Figure 5.2.  Activation of Apt4. A.) Apt4 and quencher sequences.  F denotes 
fluorescein moiety, Q denotes DABCYL moiety.  B.) Signal in relative fluorescent 
units (RFU) of Apt4 over 30 minutes at 26°C or 37°C in the absence (open marker) 
or presence of 1uM Thrombin (closed marker).  Apt4 concentration was 100nM 
while quencher oligos were 200nM final 1X signaling buffer.  The black dotted line 
represents Apt4 without quencher.  Error bars represent standard deviation from 
triplicate samples. 
The aptamer beacons were constructed by heating the oligonucleotides together 
then cooling them to room temperature; the initial fluorescent signals were stable prior to 
the addition of thrombin.  Different beacons were quenched to different extents.  The 
larger number of base-pairs gave lower backgrounds, with maximal quenching of 
fluorescence (8-fold) observed for Th.Q1 at 26°C.  Upon the addition of 1uM (saturating) 
thrombin, fluorescence was monitored and the reaction was allowed to come to 
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equilibrium over 30 minutes at either 26° C or 37° C.  As can be seen in Figure 5.2B, the 
smaller number of base-pairs generally gave larger final fluorescent signals.  
By varying the effects of base-pairing on both background and final signal were 
observed, the interactions between the anti-thrombin aptamer and its antisense quencher 
could be poised to yield different extents and kinetics of activation.  Th.Q1 is analogous 
to QDNA6 (Nutiu and Li 2003), and showed 3.7-fold activation in our hands at 37° C 
after 30 minutes, but very little activation at 26° C.  These results differed from those 
originally reported.  Nutiu and Li (2003) found ~7 fold activation of the beacon in less 
than 3 minutes at 37° C, and ~8-fold activation at 25° C after 30 minutes.  The difference 
in results may be due to the fact that our beacon is a two-piece rather than a three-piece 
construct.  Our other two-piece designed beacons showed smaller activations:  a 2.4-fold 
increase in signal over background was seen with Th.Q1-1 at 37° C, and a 3.0-fold 
increase with Th.Q1-2 at 26° C. 
As the extent of activation decreased, the rate of activation increased, as predicted 
(Table 5.1).  Th.Q1-2 showed the fastest activation at room temperature (T1/2 = 3.6 min), 
while Th.Q1-1 showed the fastest overall activation (T1/2 = 3.4 min at 37° C).   
Optimizing aptamer length for responsivity at room temperature 
Having found a two-piece aptamer beacon pair that was capable of activation 
within 30 minutes at room temperature, we began to modify other design variables to see 
what effects they might have on the extent and kinetics of activation.  Instead of 
modifying the length of the antisense quencher oligonucleotide, we instead generated a 
number of shorter aptamer beacons (Apt6, Apt7 and Apt8; Figure 5.3A).  We assayed 
the new aptamer beacons with both the antisense quencher oligonucleotide Th.Q1, which 
was previously shown to fully quench, and ThQ1-2, which provided the best activation 
and one of the best response times.  As previously, decreasing the length and strength of 
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hybridization led to greater background at room temperature (Figure 5.3B).  Th.Q1-2 did 
not quench either Apt7 or Apt8, and neither antisense quencher oligonucleotide proved 
capable of quenching Apt6 (data not shown).  
Apt4 with Th.Q1-2 and Apt8 with Th.Q1 displayed similar activation rates at 
room temperature (Table 5.1; T1/2 values of 3.6 and 3.3 minutes, respectively).  The 
observed inverse correlation between extents and rates of activation was found to be true 
over numerous aptamer beacons (Figure 5.6A).  In general, the fastest aptamer beacons 
were those that formed stable but weak complexes, and thus were poised to be perturbed 
by the addition of ligand.  It appears as though a complex that has a ΔG° value of ca. -11 
to -12 kcal / mole leads to improved kinetic performance.  Indeed, there appears to be a 
quite steep kinetic cost to hybridization energies greater than -12 kcal / mole. 
 
Figure 5.3.  Effects of Aptamer Stem Minimization. A.) Aptamer and quencher 
sequences.  F denotes fluorescein moiety, Q denotes DABCYL moiety.  The boxed 
“A” in Apt6 represents a mispairing with the quencher oligo.  B.) Signal in relative 
fluorescent units (RFU) of Apt4 and Th.Q1-2, Apt7 and Th.Q1, and Apt8 and 
Th.Q1 over 30 minutes at 26°C in the absence (open marker) or presence of 1uM 
Thrombin (closed marker).  Aptamer concentration was 100nM while quencher 
oligos were 200nM in 1X signaling buffer.  The black dotted line represents 
maximum signal for each aptamer (in the absence of quencher).  Error bars 
represent one standard deviation taken from triplicate samples. 
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Effects of quencher type and position on aptamer beacon responsivities 
Variable quenching efficiencies due to either contact quenching or FRET have 
previously been observed and measured with other hybridizing oligonucleotides 
(Dietrich, Buschmann et al. 2002; Marras, Kramer et al. 2002).  We therefore wanted to 
see to whether quencher:fluor interactions also impacted the activation kinetics of our 
fastest aptamer beacons.  We tested both Apt4 and Apt8 with two different antisense 
oligonucleotides, one which led to Q and F being in close proximity (Apt4/Th.Q1 or 
Apt8/Th.Q8) and another in which Q was separated by a two nucleotide spacer from F 
(Apt4/Th.Q8 or Apt8/Th.Q1; Figure 5.4A).  The Apt4/Th.Q1 complexes proved to be 
too stable, and did not activate at room temperature.  For the other aptamer beacons, we 
also attempted to determine whether there were performance differences between 
commonly used quencher moieties, such as BHQ-1, dabcyl and Eclipse Quencher.  
The extents of activation seen with the different the quenchers were generally 
similar irrespective of the antisense quencher oligonucleotide or aptamer beacon 
complex.  However, it appeared that aptamer beacons that displaced quencher moieties 
away from paired strands (Apt4/Th.Q1-2 and Apt 8/Th.Q8) had somewhat lower extents 
of activation but faster kinetics.  This may imply that the quencher moieties interact with 
the paired strands.  This interpretation is consistent with previous findings, in that 
duplexes labeled with quenchers showed from 2° to 10° C greater melting temperatures 




Figure 5.4.  Varying quencher and position. A.) Aptamer and quencher sequences.  
F denotes fluorescein moiety, Q denotes either BHQ-1, Dabcyl, or Eclipse 
Quencher moieties as specified in  B.) Signal in relative fluorescent units (RFU) of 
Apt8 or Apt4 with either the Th.Q1 or ThQ8 quencher oligos and three different 
quencher moieties over 45 minutes at 26°C in the absence (open marker) or 
presence of 1uM Thrombin (closed marker).  Aptamer concentration was 100nM 
while quencher oligos were 200nM in 1X signaling buffer.  The black dotted line 
represents maximum signal for each aptamer (in the absence of quencher).  Error 
bars represent one standard deviation taken from triplicate samples.   
Interestingly, quencher:strand interactions seem to affect kinetics much more 
strongly than activation.  For example, when comparing Th.Q8 (quencher displaced) with 
Th.Q1 (quencher overlap) on Apt8, the extents of activation were almost all the same 
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(Table 5.1), yet the different quenchers yielded very different rates of activation.  The 
aptamer beacons that incorporated Dabcyl had two- to three-times faster (T1/2) responses, 
while those with BHQ-1 displayed the slowest responses.  Previous comparisons between 
these quenchers also showed that Dabcyl had a lower impact on melting temperature of 
duplexes than BHQ-1 (Marras et al., 2002).  The slow BHQ-1-derivatized beacons also 
displayed the highest level of quenching (up to 94%, very similar to previously published 
value of 93% from Marras et al., 2002).  It is possible that quencher interactions with the 
duplex not only stabilize the complexes but affect the 'breathing' of the strands (Mergny 
and Maurizot 2001; Hong, Harbron et al. 2003; Voss, Meyer et al. 2004; De Cian, Guittat 
et al. 2007) that may be necessary for faster switching between conformations. 
Designing ligand accessibility 
Nutiu and Li (2003) also designed a tripartite aptamer beacon for sensing ATP, 
but found that their original design did not perform well at room temperature.  They 
hypothesized that this was because the quencher oligonucleotide "occupied" the aptamer 
core sequence, presumably preventing nascent folding and ligand interactions.  As a test 
of this hypothesis, they constructed a second ATP-sensing aptamer beacon with 
additional sequence at its 5’ end, outside of the aptamer core.  The extended binding site 
interacted with a quencher oligonucleotide with the same thermodynamic parameters as 
with the failed construct.  However, this new construct yielded activation at room 
temperature with ATP. 
We did not explicitly take into account an "occupation" parameter in our initial 
designs.  However, in Apt8/Th.Q1 the antisense oligonucleotide occupies the core 
quadruplex much more than in Atp4/Th.Q1-2, yet the two aptamer beacons have similar 
activation extents and kinetics.  That said, the core quadruplex is occupied to some extent 
by the antisense quencher oligonucleotide in both beacons. 
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Rather than merely extend previous constructs, we chose to use a similar anti-
thrombin aptamer that was already extended beyond the core quadruplex structure.  
Tasset et al. (1997) had previously selected an anti-thrombin aptamer that once again 
formed a quadruplex structure, but also contained an extended stem (aptamer 60-18[29]; 
Tasset, Kubik et al. 1997; Figure 5.1C).  Although the original (Bock) aptamer and the 
extended (Tasset) aptamer both form stacked G-quartets they contain different connecting 
loops and are thought to preferentially bind to different sites on thrombin.  The Bock 
aptamer is thought to bind to thrombin’s fibrinogen recognition exosite, while the Tasset 
aptamer binds to the heparin exosite as discussed above.  
We designed two-piece aptamer beacons based on the Tasset aptamer.  Since the 
additional base-pairs formed by the aptamer meant that the structure would be more 
difficult to denature, we used a series of antisense quencher oligonucleotides that 
hybridized with predicted ΔG° values of -11.3 kcal / mole to -15.5 kcal / mole (Figure 
5.1C; Table 5.1).  In order to explicitly test whether occupancy was a factor in aptamer 
beacon kinetic performance, an additional six base 'handle' (TCAGCA) was added at the 
5’ end; this moved the antisense quencher oligonucleotides completely outside of the 
quandruplex forming region of the aptamer (Figure 5.5A). 
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Figure 5.5.  AptH aptamer Activation. A.) Aptamer and quencher sequences.  F 
denotes fluorescein moiety, Q denotes DABCYL moiety. The boxed sequence 
forms a duplex stem while the grey represents an internal bulge characteristic of 
this aptamer.  B.) Signal in relative fluorescent units (RFU) of the sequences in (A) 
over 45 minutes at 26°C in the absence (open marker) or presence of 1uM 
Thrombin (closed marker).  Aptamer concentration was 100nM while quencher 
oligos were 200nM in 1X signaling buffer.  The black dotted line represents 
maximum signal for each aptamer (in the absence of quencher).  Error bars 
represent one standard deviation taken from triplicate samples. 
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As before, the least stable complexes (AptH/Th.Q3-2 and AptH/Th.Q5-2) gave 
the fastest activation (Figure 5.5B).  It should be noted that even when fully activated 
these aptamer beacons showed only ca. 60% of the fluorescence seen in the absence of 
the quencher.  We speculated that this might be because of protein-mediated quenching, 
but assays with protein and no quencher oligonucleotide showed full fluorescence.  Thus, 
it seems likely that an equilibrium between bound protein and bound quencher has been 
established.  This is interesting because it implies that these biosensors may have 
reversible performance.  
More stable complexes (AptH/Th.Q3-1 and AptH/Th.Q5-1) gave little or no 
activation, with the exception of the most stable, AptH/Th.Q5.  Interestingly, while 
AptH/Th.Q5 is predicted to be the most stable complex, it gave a higher background 
reading than the aptamer beacons that showed virtually no activation.  We believe that 
AptH/Th.Q5 was not fully quenched because of a competition between binding to the 
aptamer and a fortuitous dimerization of the antisense quencher oligonucleotide itself, 
and that this additional equilibria also led to the unexpected activation by thrombin.   
Even though we predicted that a stronger interaction with the antisense quencher 
oligonucleotide would be necessary for aptamer beacon complex formation, it was again 
an antisense quencher oligonucleotide that bound with a ΔG° between -11 kcal / mole and 
-12 kcal / mole that gave the best performance (AptH/Th.Q5-2; -11.3 kcal / mole).  This 
aptamer beacon had remarkable kinetic responsivity, and was almost fully activated 
within 1 minute.   
The extraordinary speed of AptH/Th.Q5-2 may have been because the quadruplex 
structure that interacts with thrombin could pre-form more readily than in previous (Apt4, 
Apt8) constructs.  In this mechanistic model, nascent interactions with the protein might 
assist in displacing the antisense quencher oligonucleotide.  A similar model has been 
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proposed for the function of so-called antiswitches (Bayer and Smolke 2005), and is 
operative in nucleic acid logic circuits based on 'toehold' sequences (Kim, White et al. 
2006; Seelig, Soloveichik et al. 2006).   
Predicting the kinetics of aptamer beacons 
Overall there was a strong correlation between the melting temperatures of the 
antisense quencher oligonucleotides and the speeds of response of the aptamer beacons 
(Figure 5.6B,C).  This trend can of course be rationalized by suggesting that the 
antisense oligonucleotide must be released prior to forming the ligand-binding 
conformation, and thus that the speeds of the various aptamer beacons were determined 
largely by the off-rates of the antisense quencher oligonucleotides.  If so, this would seem 
to argue against the relevance of the ‘protein assist’ model for AptH/Th.Q5-2 described 
above.  Interestingly, though, this aptamer beacon does have an unusually high F/Fo 
value, falling well outside of the trend previously seen in Figure 5.6A.  It may be that the 
simultaneous formation of the quadruplex and antisense duplex structures yields a low 
energy conformation that is only activated (albeit quickly) by saturating protein 
concentrations. 
Given that the apparent stabilities of several of our aptamer beacon complexes 
differed from their predicted stabilities, based on both the observed background 
fluorescence and speeds of response, we decided to directly measure the Tm values of the 
aptamer beacons.  To do this, beacons were prepared as in the activation assays, then 
ramped from 10°C to 95°C at a rate of ~0.1° C/sec and read on a real time PCR machine 
after each 1° C increase.  A revised plot of measured Tm values versus T1/2 showed a 
remarkable congruence (Figure 5.6C; r2 = 0.59), even when the thermodynamic effects 
attributed to the Eclipse Quencher were included.  These results indicate that the kinetic 
responsivities of aptamer beacons can be largely predicted based on this single parameter.  
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Figure 5.6.  Comparison of thermodynamic and kinetic parameters from Table 5.1 




Table 5.1.  Thermodynamic profiles. The melting temperature is provided in °C, 
free energy is in kcal/mol. *Blue font color corresponds to data taken at 26° C 
while red font corresponds to 37°C  ** T1/2 and rate constants only reported where 
activation is over 2 fold and the R2 value of the curve that fits the data to the 
equation T1/2=-ln(y)/rate is > 0.95 as calculated by SigmaPlot v9.0.  This table 
reports % minimum fluorescence which can be converted to quenching efficiency 
by subtracting from 100% as done in Marras et al (2002). 
 
CONCLUSIONS AND FUTURE DIRECTIONS 
The work in this entire dissertation is not in a field by itself.  Much of the work 
builds on previous aptamer based biosensor developments in both signaling and detection 
methods.  We have combined rational design with computer-assisted prediction of 
nucleic acid conformational changes to mimic aptamer selections in silico.  These 
methods however require a fair amount of in depth knowledge that cannot be 












% Min, Max 
Fluorescence
T1/2 (min)** Rate (min-1)**
5F.Apt.4 CACTGTGGTTGGTGTGGTTGG
Th.Q1 GTGACACCAACC -14.6 39.8 45.6 12 1.2; 3.7
9%, 15%; 
14%, 64%
> 30 < 0.023
Th.Q1-1 GTGACACCAAC -12.8 34.6 40.0 11 3.0; 2.4
19%, 57%; 
26%, 93%
21, 3.4 0.034, 0.21








Th.Q8 (Dabcyl) -12.7 34.4 38.5 10 4.2 12%, 54% 13.9 0.050
Th.Q8 (Eclipse) -12.7 34.4 38.8 10 4.6 9%, 46% 18.3 0.038
Th.Q8 (BHQ) -12.7 34.4 40.9 10 4.1 6%, 30% >30 < 0.023
5F.Apt.6 CACTGAGGTTGGTGTGGTTGG
Th.Q1 GTGACACCAACC -10.1 24.6 12 - -
5F.Apt.7  ACTGTGGTTGGTGTGGTTGG
Th.Q1 GTGACACCAACC -13.4 36.9 39.0 11 3.6 17%, 53% > 30 < 0.023
5F.Apt.8   CTGTGGTTGGTGTGGTTGG
Th.Q1 (Dabcyl) -12.1 32.1 33.5 10 2.3 39%, 97% 3.3 0.21
Th.Q1 (Eclipse) -12.1 32.1 35.8 10 7.7 9%, 85% 9.3 0.074
Th.Q8 (Dabcyl) -11.7 30.9 40.5 10 2.4 28%, 66% 10.6 0.065
Th.Q8 (Eclipse) -11.7 30.9 41.3 10 2.6 19%, 51% 15.2 0.046
Th.Q8 (BHQ) -11.7 30.9 45.1 10 2.6 11%, 29% > 30 < 0.023
5F.AptH TCAGCAAGTCCGTGGTAGGGCAGGTTGGGGTGACT
Th.Q5 AGTCGTTCAGGC -15.5 42.6 37.9 12 2.6 18%, 49% 4.1 0.17
Th.Q5-1 AGTCGTTCAGG -12.9 35.0 42.7 11 2.0 7%, 15% - -
Th.Q5-2 AGTCGTTCAG -11.3 29.6 33.5 10 3.0 17%, 64% < 1 > 0.69
Th.Q3-1  GTCGTTCAGGC -14.6 40.0 46.3 11 1.5 7%, 12% - -





While we have produced a number of functional aptamer biosensors from 
computationally derived and selected pools, we have not exhausted or even touched on 
the potential functional sequences present in these pools.  We have not provided a 
statistically relevant sample set to assume the sequences tested are the only sequences 
capable of switching.  In fact, we have not tested a sufficient number of sequences from 
the subset of the pool rejected by our computational sieving mechanisms to prove those 
in fact do not work.  Many of these limitations are due to synthesis costs for creating and 
purifying many different RNAs, single and dual labeled probes.  Therefore, for future 
systems, we believe computational optimization, the use of a cheap ligand, and modeling 
DNA aptamers that display tight binding to their cognate analyte and can be easily 
synthesized would be beneficial.  The designs should be able to prototype many aptamer 
sequences with a small or limited number of fluorescent beacons or alternate detection 
mechanism. 
In all of our methods, we have only calculated and compared structural 
thermodynamics to elucidate potential predictive parameters.  It is apparent that the use 
of thermodynamic minimization dynamic programming software such as Mfold and 
ViennaRNA may limit the ability of our programs to accurately identify functional 
switching structures which are also affected by kinetic limitations.  We could in the 
future use simulated annealing or kinetic information to predict biosensors that switch 
faster and with reduced backgrounds. 
The Freedonia Group reports that the in vitro diagnostic market represented   
$15.2 billion in US market in 2006.  While the use of aptamers in biomedical research is 
vast, there are currently no examples of commercial aptamer based biosensors 
development due to patenting issues.  Much of the intellectual property for aptamer 
biosensors is held by SomaLogic and Gilead (formally NeXstar).  In terms of aptamer 
 118 
based therapeutic applications, much of the intellectual property is owned by Archemix.  
However, licensing is available for aptamer biosensors deemed commercially viable.   
Thus, much of the methods presented in this dissertation could be used to increase the 
efficiency of selecting functional species from smaller random pools and reduce the time 
and cost to generate functional aptamer based biosensors making them more 
commercially attractive.  
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MATERIALS AND METHODS 
Synthesis and Purification 
All materials were synthesized as in (Hall, Hesselberth et al. 2007).  Breifly 5’ 6-
FAM moieties were introduced by 5’ phosphoramidite chemistry, while  3’ quenchers 
were incorporated through controlled pore glass (CPG) solid supports (Glen research, 
Sterling, VA) during synthesis.  The quenchers used include dabcyl (4-(4-
dimethylaminophenylazo)benzoic acid), Eclipse Quencher, and Black Hole Quencher 1 
(BHQ-1).  After deprotection samples were lyophilized and purified by HPLC (Nutiu and 
Li 2003)with the following changes: column was an XTerra MS C18 Column with 
dimentions of 4.6mm x 30mm and 2.5um bead diameter.  The two solvents were 0.1M 
TEAA and 100% acetonitrile on a nonlinear gradient from 5% to 35% acetonitrile over 
30 minutes at a flow rate of 3 mL/min.  We collected 2/3 of the main peak width showing 
absorbtion at both 260nm and 495nm.  The purified DNA was lyophilized and 
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resuspended in 100ul diH2O.  Strand concentrations were detected by UV spectroscopy at 
260nm on a Nanodrop ND-1000 (Wilmington, DE) using extinction coefficients and 
adjusted to 10uM for each oligonucleotide sequence.   
Kinetic Assays 
Assays were performed with 100nM fluorescent oligo and 200nM quencher oligo 
in 50uL reactions.  Briefly, both were mixed in signaling buffer (20mM Tris pH 8.3, 
5mM KCl, 1mM MgCl2 (Nutiu and Li 2003)), heat denatured at 90° C for 3 minutes, 
cooled to 25° C at 0.2° C/sec. They were allowed to further thermally equlibrate at room 
temperature (26° C) for 5 to 15 minutes.  Assays were carried out in Corning 96 well 
black opaque ½ area well plates (Corning, NY).  Maximum fluorescence was measured 
in the absence of quencher oligonucleotide for each assay.  Aptamers were assayed for 
activation in the presence or absence of 1uM thrombin (Haematologic Technologies, 
Essex jct., VT) on a BioTek Synergy HT (Winooski, VT) fluorescent plate reader at 
between 25.7° C and 26.8° C with a gain of either 48 or 50 such that a buffer blank 
yielded a signal of 26 RFU.  There was a lag of between 30 seconds and 1 minute after 
thrombin addition and time point 0.  Due to this lag and thermal accuracy near room 
temperature (26° C) with the Synergy HT, thermally controlled kinetic assays were 
monitored in real time on a PTI fluorimeter (Birmingham, NJ) and used to calculate rate 
constants with the equation T1/2 = -ln(0.5)/rate for the fastest constructs. 
Thermodynamic Predictions 
The DINAmelt 2-state Hybridization Server 
(http://frontend.bioinfo.rpi.edu/applications/hybrid/twostate.php) was used to predict 
melting profiles of each nucleic acid pair (Table 1; Mathews, Sabina et al. 1999; Zuker 
2003).  The following parameters were modified from the default settings: Energy Rules: 
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DNA at 26° C; Salts: 10mM Na+ (The lowest allowed although we have little Na+ in our 
reactions) 1mM Mg++; Strand Concentration: 0.1uM.  There is no way to calculate the 
effects of strand concentration through this web interface. 
Fluorescent Melting Assays 
Melts were performed on an Applied Biosystems 7300 Real Time PCR System 
(place) in skirted 96 well PCR plates from the same company using the dissociation 
method.  Assays were set up identical to the kinetic assays.  Samples were heated to 95°C 
for 15 seconds, then cooled to 10°C within the method.  Temperature ramps were 
performed from 10° C to  95° C at a rate of ~0.1° C/sec then read after each 1° C 
increase.  Samples were repeated in triplicate for three complete transition curves and 
normalized to the minimum and maximum fluorescence.  The melting temperature (Tm) 
was calculated as the peak of a curve fit through the first derivative of the normalized 
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